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ABSTRACT 
 
Metabolic Engineering and Transhydrogenase Effects 
on NADPH Availability in Escherichia coli 
 
by 
 
Joanna Ann Jan 
 
The ultimate goal in the field of metabolic engineering is improving cellular 
processes in a rational manner using engineering design principles and molecular biology 
techniques.  The syntheses of several industrially useful compounds are cofactor-
dependent.  The reducing equivalent NADPH is required in several enzymatic reactions 
leading up to the synthesis of high-value compounds like polymers, chiral alcohols, and 
antibiotics.  However, it’s a highly costly compound with limited intracellular 
availability.  This study focuses on the genetic manipulation of a whole-cell system using 
the two transhydrogenase isoforms pntAB and udhA.  Two model systems are used: 1) the 
production of (S)-2-chloropropionate and 2) the production of poly(3-hydroxybutyrate).  
Results suggest that the presence of udhA increases product yield and NADPH 
availability while the presence of pntAB has the opposite effect.  A maximum product 
yield of 1.4 mole-product/mole-glucose was achieved aerobically in a pntAB-deletion 
strain with udhA overexpression, a 150% improvement over the wild-type control strain.   
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Chapter 1 
1. Introduction 
 
1.1 Metabolic Engineering 
1.1.1 Introduction to metabolic engineering 
Metabolic engineering is a highly multidisciplinary field, combining the likes of 
chemical engineers, bioengineers, molecular biologists, computational scientists, 
biochemists, and analytical chemists, among others (Nielsen 1997, Yang 1998, Cameron 
1993).  The ultimate goal of the field is to improve upon cellular processes in a controlled 
and deliberate manner through the application of engineering design principles and 
molecular biology techniques.  Desired effects are commonly achieved via pathway 
manipulation and genetic modifications.   
Over the years, advances in recombinant DNA technology have allowed scientists 
and engineers to circumvent dependency upon random mutagenesis and instead allow for 
highly rational and precise approaches to genetic modification and subsequent screening 
processes (Koffas 1999).  The inception of this move from random mutagenesis and 
selective screening to a highly systematic approach of pathway manipulation was first 
introduced in the 1990s by Bailey (1991) and Stephanopoulos and Vanillo (1991).  As the 
field has advanced, so has the ability of scientists and engineers to incorporate rigorous 
and well-defined mutations, thereby creating strains with definitive genetic backgrounds.  
Recombinant DNA techniques, in this effect, were one of the tools that facilitated the 
onset of directed cellular modifications, alongside the emergence of extensive databases 
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on gene expression, genomic maps, and enzyme structure and refined analytical 
techniques (Keasling, 2010).   
This rational approach to pathway manipulation is the basis of metabolic 
engineering and has been defined by various authors as “the improvement of cellular 
activities by manipulation of enzymatic, transport, and regulatory functions of the cell 
with the use of recombinant DNA technology” (Bailey, 1991), “the directed improvement 
of product formation or cellular properties through the modification of specific 
biochemical reactions or the introduction of new ones with the use of recombinant DNA 
technology” (Stephanopoulos, 1998), and “the purposeful modification of intermediary 
metabolism using recombinant DNA techniques” (Cameron, 1993), to name a few.   
Clearly, recombinant DNA technology plays a large role in the execution and 
advancement of the field, though it is by all means not the sole factor.  Like other 
engineering disciplines, metabolic engineering entails two defining mechanisms: 
synthesis and analysis (Koffas 1999, Stephanopoulos 1998).  As far as synthesis is 
concerned, scientists and engineers must rely upon molecular biology techniques to alter 
enzymatic, transport, and regulatory cellular functions by introducing new gene 
expression cassettes, modifying or deleting existing genes, and/or amplifying endogenous 
enzymes.   
In order to arrive at a rational basis of identifying targets for manipulation, 
researchers must have an understanding of the physiological workings of the species in 
question, as the metabolic activities of cells are a highly intricate and networked web of 
approximately 1,000 enzyme-catalyzed reactions and selective membrane transport 
systems (Bailey, 1999).  Metabolic control analysis and biochemical systems theory are 
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two examples of available methods for identifying bottlenecks in pathways upon which 
targets for manipulation are identified.  Both are mathematical methods for modeling 
pathways and systems.  They provide insight on the effects of enzymatic levels on fluxes 
through pathways and metabolite concentrations (Keasling, 1999).   
It is necessary to practice caution when planning pathway manipulation, as 
changes can place a great amount of metabolic burden on cells, and pathways critical to 
cell survival must remain intact.  Consequently, alterations must be planned out and 
chosen in a systematic and deliberate manner.  Pathway analysis and analytical 
techniques such as metabolic flux analysis are employed, and a reiterative process 
wherein genetic changes are made, downstream effects are analyzed, and further genetic 
changes are decided upon, is used to refine the mutant strain at hand (Bailey, 1999).     
 
1.1.2 Metabolic engineering tools 
As mentioned previously, advancements in the field of metabolic engineering are 
dependent upon molecular biology techniques such as recombinant DNA, genomic maps, 
enzymatic databases, and analytical techniques, among others (Keasling, 2010).  True to 
its multidisciplinary foundation, the field calls for several experimental, computational, 
and analytical tools.   
 
1.1.2.1 Gene expression tools 
The development of refined recombinant DNA techniques spearheaded metabolic 
engineering’s turn from random mutagenesis and screening to that of rational and 
directed genetic modifications.  Molecular biology techniques are widely used.  Among 
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those frequently used are cellular transformation systems, plasmids, transcriptional 
control methods, and ‘tunable’ promoters (Stafford, 2001).  Keasling (1999) identified 
four critical characteristics that define ideal gene expression tools.  The distinguishing 
features are as follows: 1) promoters that exhibit established and consistent control of 
cells with a linear response to added inducers if they are inducible promoters, 2) the 
ability to regulate multiple gene expressions at varying levels in a simultaneous manner, 
3) gene-carrying vectors that perpetuate in the host indefinitely or for several generations 
with minimal selective pressure, and 4) minimal metabolic burden on the host.   
Cloning vectors are used to shuttle foreign DNA encoding desired enzymes 
associated with inherent or new metabolic pathways into host cells.  Genes that encode 
the enzyme are commonly put under the control of inducible promoters on high-copy 
plasmids.  These plasmids are introduced into host cells via cloning vectors, where they 
replicate, perpetuating the foreign DNA.  Plasmids are categorized according to 
incompatibility groups.  Those in the same incompatibility groups are incapable of 
coexisting stably in the same cell.  Plasmids are also characterized by their copy number, 
which is an indicator of the number of plasmids that can be maintained within the cell.  
High copy number plasmids have copy numbers of approximately 100 per cell while low 
copy number plasmids have 1-5 per cell (Keasling, 1999).   
Promoters are used to exercise control over gene expression.  Native promoters of 
heterologous genes are more often than not replaced with a host-specific promoter.  A 
linear response to inducer concentration is ideal wherein little to no gene expression is 
observed in the absence of the inducer and a direct, linear correlation is observed in the 
presence of the inducer.  Inducible promoters are of great utility as they allow for 
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inducible expression of desired pathways.  A commonly used expression system is the lac 
expression system.  A variety of plasmids containing derivatives of the lactose-inducible 
promoter are now widely available.  Promoters that are induced by starvation are of 
particular utility when applied to bioremediation of environmental contaminants.   
Oftentimes more than one enzyme controls the metabolic flux through a pathway 
(Stephanopoulos, 1997).  In such cases, directed modifications are precluded by the need 
to express more than one gene in the given pathway.   Coordinated expression of multiple 
genes can be achieved effectively using multiple inducible promoters, each controlling a 
particular gene.  A caveat of this approach is the need to add several inducers to the 
medium.  This drawback can be circumvented by implementing a method developed by 
Jensen and Hammer, which places genes under the control of promoters of different 
strengths.  However, this approach can be more labor intensive when it comes to the 
construction of promoters (Keasling, 1999).   
 
1.1.2.2 Analytical tools 
Common analytical tools for detecting metabolite concentrations are high-
performance liquid chromatography (HPLC) and gas chromatography-mass spectrometry 
(GC-MS) for detecting metabolite concentrations.   
 
1.1.2.3 Mathematical tools 
Computational and mathematical tools are essential to rational pathway 
modulation.  When coupled with experimental procedures, they facilitate pathway flux 
and flux distribution analysis.  Modeling of pathways in this manner allows for metabolic 
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flux analysis, wherein metabolic flux is defined as “the rate at which substance flows 
from the initial substrate to final pathway product” (Byrne, 2009).  An example of this is 
the rate of conversion from glucose to pyruvate during glycolysis.  Flux is a fundamental 
aspect of metabolic pathways and cellular physiology, and its control is necessary in 
order to maintain metabolite concentrations that remain with appropriate ranges for 
cellular survival (Byrne 2009, Stafford 2001).  Current methodologies for determining 
metabolic flux are based upon information such as intracellular/extracellular metabolites 
and the rate of substrate uptake, among others, for stoichiometric balances (Stafford, 
2001).   
Metabolic control analysis is used to determine the importance of enzymes in 
metabolic flux regulation.  This mathematical model expresses the sensitivity of 
metabolic flux to changes in enzymatic activity levels and is described in detail by 
Stephanopoulos et al. (1998).  In essence, it examines the relative importance and effect 
of enzymes on fluxes and metabolite concentrations.  It is a powerful quantitative tool 
when examining steady state properties of biochemical reactions both theoretically and 
experimentally.   
 
1.1.3 Metabolic engineering applications 
 The primary objective of metabolic engineering is efficient and robust production 
of desired products for commercial uses. As such, the scope of the field is immense and 
relevant in pharmaceutical, environmental, chemical, food, and health care industries, to 
name a few, and can be grouped into the following five broad categories, as delineated by 
Cameron et al.  (1993). 
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1.1.3.1 Enhanced yield of native products 
In this instance, metabolic engineering is applied with the intent of increasing the 
productivity of naturally produced compounds of host microorganisms.  Native 
compounds such as catabolic end products, antibiotics, vitamins, amino acids, and 
polymers, among others, hold great value in industrial realms (Cameron, 1993).  
Enhanced productivity is a major incentive as it allows for cost-effective commercial 
applications.  Efficient ethanol production, for example, has been studied extensively by 
several groups (Brau 1987, Tolan 1987, Ingram 1987).  Metabolic engineering of 
antibiotics (Chen 1988, Hutchinson 1992) is particularly attractive from a technical point 
of view as they are more often than not positively regulated and have a clustered 
arrangement of antibiotic genes, allowing for the overexpression of antibiotic gene 
regulators and more effortless cloning when designing genetic modifications to host 
organisms (Chater, 1990).   
 
1.1.3.2 Extended substrate range for host utilization 
Metabolic engineering has also been used to extend the substrate range for host 
organism growth and product formation.  By diversifying substrate options, organisms 
can be cultured on more cost-efficient substrates, like in the case of ethanol production on 
cellobiose and cellotriose (Wood, 1992) or biosurfactant production on industrial wastes 
such as whey and lactose (Koch 1988, Kumar 1992).   
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1.1.3.3 Enhanced degradation of toxic products 
Another beneficial application of metabolic engineering is the introduction of 
novel catabolic processes for toxic chemical degradation.  Modifications such as these are 
difficult, as they can be associated with unfavorable energetics of substrate utilization in 
addition to challenging substrate transport phenomena, substrate toxicity, and low 
substrate concentration (Tong, 1993).  Engineering microbes for bioremediation is an 
attractive means for the removal of industrial pollutants as it provides an alternative, 
green, and economical means of treatment.  Examples include bioadsorbents for 
sequestering heavy metals (Sousa, 1998) and the catabolism of camphor and naphthalene 
(Chakrabarty, 1974).   
 
1.1.3.4 Enhanced yield of nonnative products 
In some situations the inactivation or overexpression of unique enzymes or 
pathways activates alternative enzymes or pathways capable of restoring order and 
ultimately negating the desired effect.  This notion is especially apparent in the 
production of primary metabolites in the highly regulated and controlled central 
metabolism (Yang, 2007).  Fortunately, host organisms lacking the necessary metabolic 
pathway are still capable of producing target metabolites.  On such occasions, the 
necessary pathway is introduced to the non-native producing host cells in order to arrive 
at the desired product in an efficient manner.  A large amount of work in this area of 
metabolic engineering has been in the realm of antibiotics with a primary focus on the 
discovery of novel, hybrid antibiotics (Cameron 1993, Hopwood 1985).  Another 
example is the production of polymers.  An example is polyhydroxybutyrate (PHB) in 
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Alcaligenes eutrophus, which has been cloned and expressed in Escherichia coli 
(Sanchez, 2006).   
 
1.1.3.5 Enhanced cellular properties 
The objective with this application of metabolic engineering is enhancing cellular 
fitness and hardiness by improving host properties ranging from increased growth rate to 
toxic metabolic intermediate resistance, optimized substrate utilization, and ultimately 
enhanced productivity and product yields.  Examples include growth in an oxygen-
limiting environment (Bailey 1990, Khosla 1988) and insulin response to glucose 
(Hughes, 1992).   
 
1.1.4 Recent advances and applications in metabolic engineering 
In this day and age metabolic engineering is a valuable tool that is utilized across 
several sectors in industry.  The development of increasingly refined and intuitive 
engineering tools has fueled the growth of the field itself, and note-worthy advances are 
being made when it comes to translating the discipline into tangible products and 
processes of high value and practical use.  Two applications that have generated 
considerable interest as of late reside in the pharmaceutical and energy industries.  This 
section focuses on recounting the impact of the field in these two industries, among 
others.   
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1.1.4.1 Natural product drug discovery 
Khosla and Keasling published a recent review article highlighting the 
development of metabolic engineering along with its applications to drug discovery and 
development in 2003.  The utility of metabolic engineering techniques in the 
pharmaceutical industry is immense.  The turnaround rate in the drug discovery pipeline 
is lacking.  For every successful candidate that makes its way to market, there are, on 
average, five to ten thousand failed compounds behind it (Khosla, 2003).  Throw in the 
fact that it takes about 10-15 years for a successful drug to go from ground zero to market 
on top of that, and one can see the need for a rational means of producing viable drug 
candidates from cost-efficient starting materials in large quantities and in heterologous 
hosts (Khosla, 2003).   
The majority of effective drugs are of natural origin or a derivative of natural 
products.  In fact, in the 1990’s approximately 80% of drugs were either natural or 
naturally-derived products (Li, 2009).  Examples of such are potent anticancer 
(doxorubicin, taxol), antibacterial (erythromycin, streptomycin), and immunosuppressant 
(cyclosporine) drugs.  However, the time frame spanning from 2001 to 2008 experienced 
a 30% drop in natural product-based drug design (Li, 2009).  What spurred this 
noticeable trend?   A prominent challenge the pharmaceutical industry faces is related to 
technical shortcomings when synthesizing and identifying new compounds with desirable 
qualities.  Fortunately, this decline is not projected to be long lived, with new 
technologies such as metabolic engineering, synthetic biology, and smart screening 
methods for new natural product drug discovery on the horizon.   
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The use of heterologous hosts for new drug production is dependent upon the 
introduction of new genes or manipulation of inherent genes in biological pathways.  It 
entails rational genetic overexpression, underexpression, or deletion in metabolic 
pathways in order to streamline product synthesis and avoid bottlenecks within inherent 
and/or newly introduced pathways.  The past decade has been marked by metabolic 
engineering-fueled discoveries in the pharmaceutical industry (Khosla, 2003).  Common 
classes of natural products, as delineated by Khosla et al., wherein metabolic engineering 
has made an impact are presented below.   
 
1.1.4.1.1 Isoprenoids 
Isoprenoids are a diverse class of natural compounds composed of over 50,000 
known compounds including terpenoids and carotenoids (McCaskill, 1997).  Carotenoids 
are powerful antioxidants, and research has shown that they are effective in preventing 
cardiovascular disease and cancer (Sandmann, 1999).  They are naturally-occuring 
compounds synthesized by plants and microorganisms.  Sandmann et al. overcame their 
limited availability via heterologous expression of carotenoid genes from various host 
species in Escherichia coli.  
Terpenoids are effective as antifungal, antibacterial, and anticancer agents 
(Khosla, 2003).  Microbial systems such as Escherichia coli and Saccharomyces 
cerevisiae are characterized by poor expression of the terpene cyclase genes (Martin, 
2001).  However, these limitations can be overcome when applying metabolic 
engineering principles.  The anti-malaria drug, artemesinin, was the subject of a study by 
Martin et al. in a recent paper published in 2003.  Martin et al. engineered the mevalonate 
12 
 
 
pathway in Escherichia coli by synthesizing and expressing the gene encoding 
amorphadiene synthase to increase production of the artemisinin precursor amorphadiene 
and achieved 24 µg equivalent/mL.   
 
1.1.4.1.2 Polyketides 
Polyketides are a class of natural metabolites derived from acyl-CoA monomers.  
Commonly used polyketides range from antibacterials (erythromycin, tetracyclin) to 
anticancer agents (doxirubin) to cholesterol-lowering agents (lovastatin) and 
agrochemicals (spinosyn) (Khosla, 2003).  Their synthesis is controlled by a polyketide 
synthases.  The greatest limitation when examining and manipulating the synthesis of 
polyketides are due to challenges associated with their natural host.  Directed engineering 
approaches are being used to for high productivity synthesis of these compounds.  An 
example of such is the transfer of biosynthetic capabilities into a heterologous host.  The 
horizontal transfer of polyketide pathways into heterologous hosts has been examined by 
Pfieifer et al. (2001), particularly in the microbial hosts Streptomyces coelicolor and 
Escherichia coli.  The overproduction of known metabolites such as the anti-tumor agent 
epothilone in Streptomyces coelicolor has also been documented (Khosla, 2003).   
 
1.1.4.1.3 Non-ribosomal peptides 
Metabolic engineering principles have been applied to the production of non-
ribosomal peptides, perhaps the most well-known of which is penicillin.  An example in 
this area is the development of a direct fermentation process for the production of 
industrially useful intermediates (Khosla, 2003). 
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1.1.4.1.4 Carbohydrates 
In addition to fueling advances in the production of the aforementioned 
compounds, metabolic engineering has made strides in the synthesis of vitamins like 
folate and riboflavin as well as sugars such as mannitol and sorbitol, among others.  The 
focus in this area is the discovery of glycosidic drug candidates.  The biosynthesis of 
these compounds revolves around redox, amino transfer, and methyl transfer processes 
(Khosla, 2003).   
 
1.1.4.2 Biofuels from renewable resources 
Due to rising energy costs and environmental concerns such as pollution and 
climate change, there has been a push in engineering biofuels from renewable sources.  
Renewable resources like agricultural crops, biomass, and waste materials are used to 
generate biofuels (Cheng, 2011).  Currently, the most commonly used biofuels are those 
derived from starches (corn) or sugar cane, while the most widely used biodiesels are 
those from vegetable oils or animal fat (Fortman 2008, Cheng 2011).  The conversion of 
renewable resources, like biomass-derived sugars, into transportation fuel was first 
conceptualized back in the 1970s (Fortman 2008, Stephanopoulos 2007).  Over the years, 
great strides have been made in the field, alongside advancements in genomics and 
metabolic engineering.  
Bioethanol is the chief biofuel of the worldwide market, used to make gasoline-
ethanol mixtures like E85, consisting of 85% ethanol and 15% gasoline.  In 2008, 
bioethanol production worldwide stood at 17.34 billion gallons (Cheng, 2011).  As 
mentioned previously, it is commonly produced from sugar cane or corn feedstocks.  
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Unfortunately, sources like these place considerable strain on limited agricultural 
resources.  Furthermore, bioethanol is characterized by low energy density, containing 
30% less energy content than gasoline (Atsumi 2008, Keasling 2008).   Barring such 
hindrances, an intuitive approach to bioethanol production utilizes glycerol, a common 
biodiesel waste, in the production process.  Glycerol contains highly reduced carbons that 
are capable of being converted into fuels or other reduced products such as 1,2-
propanediol (Clomburg and Gonzalez, 2011) at greater yields than those associated with 
common sugars (Gonzalez, 2008).  Enterobactor aerogenes HU101 has shown promising 
results utilizing glycerol for ethanol production (Ito, 2005) and Gonzalez et al. (2008) 
have characterized key pathways for the fermentative metabolism of glycerol in E. coli, 
indicating potential for producing biofuel from biodiesel waste and presenting it as a 
platform for the conversion of glycerol into biofuels.   
More sustainable alternatives are biofuels derived from lignocellulosic materials; 
the most readily available and renewable organic resource at our disposal (Aristidou, 
2000).  Lignocellulosic materials present several advantages.  For one, its production is 
not reliant upon food-based agricultural resources such as corn or sugarcane.  It is also a 
readily available biopolymer, and it can be engineered to produce fossil-fuel 
replacements via new biosynthetic pathways (Keasling, 2008).  These materials can be 
used for biofuel production because they have high cellulose and hemicellulose content.  
Cellulose is a high molecular weight and linear glucose polysaccharide containing over 
10,000 sugar units, while hemicellulose is a low molecular weight and heterogeneous 
polysaccharide containing 100-200 sugar units.  Hemicellulose monomers include 
hexoses such as glucose, galactose, and mannose, as well as pentose such as xylose and 
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arabinose.  Studies are being done on the conversion of these source materials into 
economically viable biofuels.   
Isopropanol, a secondary alcohol produced by microbes (Osburn, 1937), has been 
explored as a sustainable biofuel.  It is naturally produced in several species of 
Clostridium and has been studied extensively in these species.  However, due to limited 
knowledge in regards to metabolic regulation in Clostridium strains as well as laborious 
genetic manipulations, a more optimal approach entails moving and engineering a 
synthetic pathway into a more desirable host.  In Clostridium species isopropanol is 
produced from the acetone pathway, and a previous study by Bermejo et al. (1998) 
moved four genes from Clostridium acetobutylicum into Escherichia coli and resulted in 
a mutant strain capable of producing near-equivalent levels of acetone as the native host.  
Hanai et al. engineered a synthetic pathway in E. coli by introducing genes from 
Clostridium species into E. coli K-12 MG1655 to produce isopropanol from acetyl-CoA 
via acetone.  The resultant strain produced a high titer of isopropanol (81.6 mM), which 
exceeded that of the best reported strain, Clostridium beijerinckii (30 mM).   
n-Butanol is another biofuel under investigation.  Its energy content (27 MJ/L) is 
similar to that of gasoline (32 MJ/L) (Atsumi, 2008).  Its native host is Clostridium 
acetobutylicum.  A previous study by Fontaine et al. examined n-butanol production in by 
cloning and expressing the recombinant AdhE2 gene, responsible for n-butanol 
production, into E. coli.  Another metabolic engineering approach entails deleting 
competing host pathways; for example, pathways that compete with n-butanol for Acetyl-
CoA and NADH.  In fact, n-butanol production has been shown to increase three-fold 
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over wild-type levels when ldhA, adhE, frdBC, pta, and fnr are deleted from wild-type E. 
coli strains (Atsumi, 2008).   
These are just a few examples of strides being made in biofuel production from 
renewable resources.  Metabolic engineering provides valuable tools for engineering 
heterologous hosts for the cost effective and efficient production of biofuels, providing 
sustainable alternatives over the traditionally and widely-used ethanol and gasoline.  
When examining advances in this field, focus is placed on cost-effective approaches that 
alleviate environmental burdens, and in order to achieve this goal, product yield, titer, 
and productivity must all be improved.   
The field can be further extended by considering waste and byproducts in the 
biofuel industry, an example of which is glycerol. Crude glycerol accumulation is 
observed during the production of biodiesel and bioethanol and in such large quantities 
that disposal costs become a major factor.  While accumulated glycerol can be converted 
into higher value products via biological or chemical transformations, its purification 
process is costly and uneconomical.  However, E. coli has been shown to metabolize 
glycerol fermentatively.  As such, engineering E. coli for the production of chemicals and 
fuels shows promise.  (Yazdani, 2010) 
 
1.1.5 Cofactor and pathway engineering 
A commonly implemented approach in metabolic engineering begins by first pin-
pointing the rate-limiting step in a given pathway and then manipulating enzyme levels to 
moderate production.  While this marks a traditional approach in the field, it is not 
without its limitations.  The method takes into account enzymatically controlled rate-
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determining steps in pathways.  However, once the bottleneck is alleviated through 
enzyme overexpression, deletion, or addition, further considerations may need to be taken 
into account.  A lack of a complete understanding of central cellular metabolism and the 
integrated nature of its numerous processes is a common obstacle in attempts to design 
optimal pathways for efficient production.   
Cofactors, for instance, are known to play a hand in numerous biochemical 
reactions.  Cofactor engineering presents itself as a powerful tool in the field of metabolic 
engineering.  When examining cofactor-dependent systems, a logical approach would 
incorporate cofactor manipulation. 
Cofactors are non-protein components that provide enzymes with chemically 
versatile functions.  They are capable of binding to enzymes in a reversible manner 
without undergoing any major chemical alterations in the process (Garrett, 2010).  
Therefore, unlike metabolites, cofactors are able to undergo a change in state during an 
enzymatic reaction while maintaining the capability of returning to their original state via 
a regenerative reaction.  However, the high cost associated with such cofactors is a 
prominent roadblock in commercial applications (Zhao, 2003).  Thus, efficient and cost-
effective cofactor regeneration is needed.   
Cofactor pairs commonly act as donors and/or acceptors of reducing equivalents 
in vivo, effectively shuttling electrons and undergoing oxidation and/or reduction.  
Common cofactor pairs are NADH/NAD+, CoA/Acetyl-CoA, NADPH/NADP+, and 
ADP/ATP, among others.  These pairs undergo reversible transformations between their 
oxidized and reduced states, and the ratio between the pairs is known to affect pathways.  
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As a result, they can be manipulated and used as a control parameter when altering and 
modulating cellular metabolism.   
 
1.1.5.1 NADH/NAD+ cofactor pair 
Previous work has been performed on investigating the effects of cofactor 
engineering.  The cofactor pair NADH/NAD+ has a major role in microbial catabolism 
wherein the nicotinamide adenine dinucleotide cofactor (NAD+) oxidizes a carbon source 
and produces the reducing equivalent NADH.  NAD+ regeneration is essential to cellular 
survival.  NADH/NAD+ cofactor engineering has been effective in boosting the 
productivity of industrially-relevant compounds such as ethanol and 1-2, propanediol 
(Berrios-Rivera, 2003).  This laboratory, for example, has examined the role and effects 
of NAD+, known to take part in over 300 redox reactions (Berrios-Rivera, 2002).  1,2-
propanediol production was achieved by overexpressing the methyl-glyoxal synthase 
enzyme from Clostridium acetobutylicum and the glycerol dehydrogenase enzyme from 
E. coli.  A lactate dehydrogenase deletion was also incorporated to eliminate a competing 
NADH-dependent pathway.  This study found that by increasing NADH availability 
under anaerobic conditions, metabolic flux redistribution followed and resulted in a 
higher ethanol to acetate ratio (Berrios-Rivera, 2003).   
 
1.1.5.2  CoA/Acetyl-CoA cofactor pair 
The cofactor pair CoA/Acetyl-CoA has also been under investigation.  Both CoA 
and Acetyl-CoA are involved in several metabolic pathways, acting as essential 
intermediates and regulators (Chohnan, 1997).  For instance, acetyl-CoA acts as a 
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substrate during the synthesis of esters (Horton, 2003) and also plays a role in the 
production of poly(3-hydroxybutyrate), PHB, a biodegradable polymer (Lee 1995, 
Sanchez 2006, Wong 2008).  Vadali et al. performed a study on CoA and acetyl-CoA 
levels in an aerobic batch reactor along with the effects of overexpressing pantothenate 
kinase, an upstream enzyme that catalyzes the rate-limiting step in the synthesis of CoA 
(Song, 1992).  They observed a 10-fold increase in intracellular CoA levels and a 5-fold 
increase in acetyl-CoA levels, resulting in carbon flux increase to acetate production 
pathway.   
 
1.1.5.3  ADP/ATP cofactor pair 
 ATP is a common phosphorylating agent for supplying energy in several 
biochemical processes.  The regeneration of ATP from ADP has been previously 
explored using both enzymatic (Chenault, 1987) and whole-cell (Endo 2001, Fujio 1985) 
based methods.  Enzymatic methods are typically quite costly, as they call for costly 
substrates and enzymes.  Fujio et al. performed studies on whole-cell ATP regeneration 
in Brevibacterium ammoniagenes cells grown in medium supplemented with magnesium 
ions and phytic acid, resulting in increased ATP formation.  
 
1.1.6    Research objectives 
Primary research encompasses metabolic engineering of pathways in E. coli to 
increase NADPH availability, allowing for higher productivity and product yields of 
NADPH-dependent and industrially relevant compounds.  Therefore, the ultimate 
objective of this study is the application of rational genetic modifications using pathway 
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and cofactor engineering to characterize NADPH availability by determining product 
yield of cofactor-dependent products in E. coli.  This objective is achieved using classic 
metabolic engineering strategies such as overexpression and deletion of specific 
enzymes.   
In the course of this study, cofactor constraints are taken into consideration in 
efforts to attain high product yields and productivities when catalyzing the conversion of 
substrate to product.  The cofactor pair of interest is NADPH/NADP+.  The reducing 
agent, NADPH, is an important coenzyme required in several biological reactions.  The 
implementation of whole-cell fermentation systems in this regard allows for more robust 
and cost-effective synthesis of compounds. 
The effects of two transhydrogenases, pntAB and udhA, on NADPH availability 
are examined.  PntAB, a membrane-bound, proton-translocating transhydrogenase, and 
UdhA, a soluble, energy-independent transhydrogenase, function in NADPH metabolism 
of E. coli.  These two transhydrogenease isoforms transfer electrons between NAD and 
NADP.   
Transhydrogenase mutants and overexpression plasmids are used to manipulate 
expression levels of these transhydrogenases.  By modifying transhydrogenase expression 
levels, subsequent effects on NADPH availability are assessed in two unique model 
systems: 1) using the production of (S)-2-chloropropionate catalyzed by the 
NADPHdependent 2-haloacrylate reductase (CAA43), and 2) using the production of 
poly(3-hydroxybutyrate) (PHB), a biodegradable polymer.    
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Chapter 2 
2.  Materials and Methods 
 
 This chapter contains the general methods and protocols used to conduct the 
research presented herein.  Material and methods are described in detail in corresponding 
sections.   
 
2.1 Bacterial Strains and Plasmids 
2.1.1  Strains and plasmids 
 The E. coli strains and plasmids used in this work are presented in Table 2-1.   
 
2.1.2  Bacterial strain construction 
Single udhA and pntAB transhydrogenase mutants and a double transhydrogenase 
mutant were constructed in wild type MG1655 E. coli.  The udhA mutant was constructed 
using the one-step inactivation method first described by Datsenko and Wanner (2000).  
The primers used for introducing the kanamycin cassette in the udhA gene were as 
follows:   
Forward: ATGCCACATTCTACGATTACGATGCCATAGTAATAGGGTGTA- 
GGCTGGAGC-TGCTTC  
Reverse: GTTTCTAGCCCAATGTTCTGTAACGCCAGCGAATCGCATATG- 
AATATCCTCCTTAG 
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Table 2-1.  List of E. coli strains and plasmids used in this study. 
 Genotype References 
Strain   
MG1655 Wild type E. coli (F
-
 λ
-
) ATCC 47076 
MBS601 MG1655 ∆udhA This study 
MBS602 MG1655 ∆pntAB This study 
MBS603 MG1655 ∆pntAB ∆udhA This study 
Plasmids   
pDHC29 Cloning vector, Cm
R
 (Phillips et al. 2000) 
pCAA43 2-Haloacrylate reductase 
gene from Burkholderia sp. 
in pTrc99A, Amp
R
  
(Kurata et al.  2005) 
pAeT29 Encodes β-ketothiolase, 
NADPH-dependent 
acetoacetyl-CoA reductase, 
and PHB synthase enzymes 
from Alcaligenes eutrophus, 
Amp
R 
ATCC 75207 
pPNTAB Proton-translocating 
pyridine nucleotide 
transhydrogenase gene 
(pntAB) from E. coli, in 
pDHC29, Cm
R
 
This study 
pUDHAC Soluble pyridine nucleotide 
transhydrogenase gene 
(udhA) from E. coli in 
pDHC29, Cm
R
 
This study 
 
 
The underlined portion of the sequence is homologous to udhA, and the non-underlined 
portion is homologous to the kanamycin region of pKD4.  This construct was 
denominated MBS601 and was constructed by Dr. Irene Martínez Basterrechea (Dr. 
San’s lab, Rice University).  The pntAB mutant was constructed using P1-phage 
transduction with the strain JW1594 from the Keio Collection as the donor strain (Baba, 
2006).  This construct was denominated MBS602 and was constructed by Dr. Irene 
Martinez Basterrechea (Dr. San’s lab, Rice University).   
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 The udhA overexpression plasmid, pUDHAC (Cm
R
) was constructed by moving 
udhA from the overexpression plasmid, pUDHAK (Km
R
) previously constructed by 
Sanchez et al. (2006).  The udhA gene (1.6 kb) was digested with ApaI and SpeI and 
cloned into pDHC29(Phillips, 2000) multiple cloning site.  This construct was 
constructed by Dr. Yipeng Wang (Dr. Bennett’s lab, Rice University).   
The pntAB overexpression plasmid was constructed by amplifying the pntA and 
pntB genes from E. coli MG1655 chromosomal DNA with 300 bp before and 20 bp after 
the sequence.  The native promoter was included in the construct.  The primers used for 
the construct were as follows: 
 Forward: TTATCTGCAGAAGTAGTGATTCGTGC 
 Reverse: ATTATATCGATCTCAGCAGAGGCCGTC 
The forward and reverse primers included a PstI and ClaI restriction site (underlined), 
respectively.  The PCR product was digested with PstI and ClaI and cloned into pDHC29 
(Cm
R
).  This construct was constructed by Dr. Irene Martinez Basterrechea (Dr. San’s 
lab, Rice University).   
 The 2-Haloacrylate reductase expression plasmid was constructed by amplifying 
the CAA43 gene from pET101-TOPO generously given to us by Kurata et al.  The 
primers used for the construct were as follows: 
 Forward: CCGCCATGGGAATGGTAATGGCAGCGGTAATTCATAAG 
 Reverse: CGCTCTAGACTACGCTTGCGGAAGCAAAACAAT 
The forward and reverse primers included a NcoI and XbaI restriction site (underlined), 
respectively.  The PCR product was digested with NcoI and XbaI and cloned into 
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pTrc99A (Amp
R
).  This construct was constructed by Dr. Yipeng Wang (Dr. Bennett’s 
lab, Rice University).   
 
2.2 Culture medium 
 Chemicals used in the following procedures were purchased from Sigma-Aldrich 
(St. Louis, MO), unless denoted otherwise.   
2.2.1 Cultivation medium 
 Luria-Bertani (LB) broth medium contained 10 g/L tryptone (Amresco, Solon, 
OH), 5 g/L yeast extract (BD Biosciences, Franklin Lakes, NJ) and 10 g/L NaCl.  The LB 
medium was autoclaved at 121°C for 20-35 minutes, depending upon the volume of 
liquid being autoclaved.  After autoclaving, glucose, antibiotics, and other various 
compounds were added aseptically as need be in accordance with each experiment.   
 For aerobic and anaerobic (S)-2-chloropropionate production shake flask 
experiments, antibiotics were added at concentrations of 100 mg/L ampicillin and 35 
mg/L chloramphenicol for strain selection and plasmid stability.  The LB medium used 
was supplemented with 1% glucose as specified in experimental procedures.  (Kurata 
2005, Kurata 2008) 
 For aerobic poly(3-hydroxybutyrate) (PHB) production experiments, a cocktail 
mixture of ampicillin, carbenicillin, and oxacillin was added at a concentration of 200 
mg/L.  The LB medium used was supplemented with 2% glucose as specified in 
experimental procedures.  (Sanchez 2006) 
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2.2.2 Defined M9 medium without ammonium chloride 
 M9 minimal growth medium contains 6 g/L Na2HPO4, 3 g/L KH2PO4, 0.5 g/L 
NaCl.  CaCl2, MgSO4, and Vitamin B1 (thiamine) were added to the medium after 
autoclaving to final concentrations of 1 mM, 0.1 mM, and 1 µg/mL, respectively.  The 
medium was supplemented with 100 mg/L ampicillin, 35 mg/L chloramphenicol, and 2% 
glucose unless indicated otherwise.      
 
2.2.3 Agar plates 
 Cells were grown on agar plates for strain selection and maintained for short term 
storage.  Plates were prepared using LB and 15 g/L of technical agar.  The mixture was 
autoclaved and allowed to cool to approximately 55 °C.  Upon cooling, antibiotics were 
added as specified by each individual experiment prior to pouring approximately 25 mL 
of the agar mixture into each plate.   
 
2.2.4 Storage medium 
 Glycerol stocks were used to maintain strain viability during long term storage.  
Stocks were prepared using 300 µL of glycerol freezing solution (50% glycerol, filter 
sterilized) and 700 µL of overnight culture.  The mixture was vortexed and left at room 
temperature for about 30 minutes to allow cells to acclimate to the new environment prior 
to storage at -80 °C.   
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2.3. Cell Cultivation 
2.3.1(S)-2-chloropropionate production experiments 
 Cultures for (S)-2-chloroproprionate production experiments were performed 
using 500 mL shake flasks containing 150 mL of LB media containing the appropriate 
antibiotics.  No glucose was present in the medium a carbon source.  Overnight 
precultures were prepared by inoculating a single colony into 3 mL LB supplemented 
with appropriate antibiotics, 1% glucose content, and incubated overnight at 37 °C and 
250 rpm.  Cultures were inoculated with 1.5 mL (1% v/v) of the overnight culture.  After 
inoculation cells were grown in an Excella E25 rotary shaker (New Brunswick Scientific, 
Enfield, CT) at 30 °C and 250 rpm.  When the optical density at 600 nm reached 
approximately 0.5, isopropyl-1-thio-β-D-galactopyranoside (IPTG) was added to a final 
concentration of 1 mM to the medium.  Cells were cultivated in an Excella E25 rotary 
shaker (New Brunswick Scientific, Enfield, CT)at 30 °C and 250 rpm for approximately 
18 hours in the presence of IPTG prior to being harvested for the production of (S)-2-
chloroproprionate under aerobic and anaerobic conditions.   
 
2.3.1.1 Aerobic shake flask experiments 
 Aerobic shake flask experiments were performed using 250 mL shake flasks 
containing 20 mL of defined M9 media.  2-chloroacrylate was added to the medium to a 
final concentration of 50 mM and the mixture was pH adjusted to 7.0 with 6 N HCl.  
Cultured cells were harvested by centrifugation, washed, and resuspended in the reaction 
medium to a final concentration of approximately 10 OD600 to monitor the degradation of 
2-chloroacrylate into (S)-2-chloropropionate.  A volume of 20 mL of resuspended culture 
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was transferred aseptically to each flask.  Flasks were capped with foam stoppers.  The 
reaction was carried out in in an Excella E25 rotary shaker (New Brunswick Scientific, 
Enfield, CT) at 37 °C and 250 rpm.  Samples of the cultures were taken at 0 and 6 hours 
and analyzed for (S)-2-chloropropionate and extracellular metabolite production. 
 
2.3.1.2 Anaerobic shake tube experiments 
 Anaerobic shake tube experiments were performed using 15 mL amber-colored 
glass tubes containing 14.5 mL of defined M9 media.  2-chloroacrylate was added to the 
medium to a final concentration of 50 mM and the mixture was pH adjusted to 7.0 with 6 
N HCl.  Cultured cells were harvested by centrifugation, washed, and resuspended in the 
reaction medium to a final concentration of approximately 10 OD600 to monitor the 
degradation of 2-chloroacrylate into (S)-2-chloropropionate.  A volume of 14.5 mL of 
resuspended culture was transferred aseptically to each tube to ensure anaerobic 
conditions.  Tubes were capped with a rubber septum.  The reaction was carried out in in 
an Excella E25 rotary shaker (New Brunswick Scientific, Enfield, CT) at 37 °C and 250 
rpm.  Samples of the cultures were taken at 0 and 6 hours and analyzed for (S)-2-
chloropropionate and extracellular metabolite production. 
 
2.3.2 Poly(3-hydroxybutyrate) production experiments 
2.3.2.1 Aerobic shake flask experiments 
 Overnight precultures were prepared by inoculating a single colony into 5 mL LB 
supplemented with appropriate antibiotics with no glucose content and incubated 
overnight at 37 °C and 250 rpm.  Cultures were inoculated with 1% v/v of the overnight 
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preculture (e.g. 0.5 mL overnight preculture into a 250 mL flask containing 50 mL LB 
medium).  Aerobic shake flask experiments were performed using 250 mL shake flasks 
containing 50 mL of LB media.  The LB media was supplemented with a cocktail 
mixture of ampicillin, carbenicillin, and oxacillin to a final concentration of 200 mg/L 
and 2% glucose.  Flasks were capped with foam stoppers and grown in in an Excella E25 
rotary shaker (New Brunswick Scientific, Enfield, CT) at 37 °C and 250 rpm.  Samples 
of the culture were taken at 24 and 31 hours and analyzed for poly(3-hydroxybutyrate) 
and extracellular metabolite production. 
 
2.4 Analytical Techniques 
2.4.1 Cell Density 
 Cell density (OD) was taken at 600nm in a DU 800 spectrophotometer (Beckman 
Coulter, Irving, TX).  Culture samples were diluted, as appropriate, with LB medium to 
maintain readings in the linear range of the spectrophotometer (0.1-0.4 OD600).   
 
2.4.2 Analysis of extracellular metabolites 
 In order to quantify extracellular metabolites, 1 mL of the fermentation broth was 
sampled and centrifuged at 13,000 g for 3 minutes in a microcentrifuge.  The supernatant 
was filtered through a 0.2 µm PTFE syringe filter and stored frozen for HPLC analysis.  
A Shimadzu-10A HPLC System (Shimadzu Scientific Instruments, Columbia, MD) 
equipped with a cation-exchange column (HPX-87H, BioRad Labs, Hercules, CA), a UV 
detector (Shimadzu SPD-10A), and a differential refractive index detector, RI, (Waters, 
Milford, MA) was used to detect extracellular metabolites such as glucose, succinate, 
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lactate, and acetate, among others.  A solution of 2.5 mM H2SO4 was used as the mobile 
phase and operated at a0.5 mL/min flow rate.  The column was operated at 55°C.   
 
2.4.3 PHB Extraction  
 Samples for PHB extraction were withdrawn aseptically after 24 and 31 hours of 
cultivation.  A 20 mL sample was withdrawn from the aerobic shake flasks at each 
timepoint, washed three times with 0.15 N NaCl and resuspended in 15 mL of 0.15 N 
NaCl.  Resuspended cells were transferred to preweighed and predried glass tubes and 
dried to constant weight using dry nitrogen.  A control tube containing 15 mL of 0.15 N 
NaCl was concurrently dried to constant weight and subtracted from the sample’s 
measured dry cell weight.  Samples of PHB-containing dry cell mass were digested in 2 
mL of concentrated H2SO4 for 45 minutes at 100°C on a heating block.  After cooling on 
ice, 10 mL of 0.014 N H2SO4 was added to the tubes and vortexed to ensure rapid 
mixing.  Extracted samples were diluted once more with 0.014 N H2SO4 to a final 
dilution factor ranging from 12-72, as needed.  (Sanchez, 2006) 
 
2.4.4 Analysis of PHB production 
 PHB production was quantified using a Shimadzu-10A HPLC System (Shimadzu 
Scientific Instruments, Columbia, MD) equipped with a cation-exchange column (HPX-
87H, BioRad Labs, Hercules, CA), a UV detector (Shimadzu SPD-10A), and a 
differential refractive index detector, RI, (Waters, Milford, MA).  Approximately 1 mL of 
the diluted extract was centrifuged at 13,000 g for 3 minutes in a microcentrifuge.  The 
supernatant was filtered through a 0.2 µm PTFE syringe filter and stored chilled for 
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HPLC analysis.  The mobile phase used was a 2.5 mM H2SO4 solution at a flow rate of 
0.6 mL/min.  The column was operated at 55°C.   
 The amount of PHB produced was calculated based upon a method developed by 
Karr et al. (Karr et al., 1983).  The absorbance of crotonic acid was measured at 210 nm 
with a retention time of 25.2 minutes.  The amount of crotonic acid derived from PHB 
was calculated using a known standard calibration curve of crotonic acid.  PHB content 
was estimated based upon the amount of crotonic acid detected using the previously 
determined conversion rate of PHB to crotonic acid of 1.81, as described by Taguchi et 
al. (Taguchi et al., 2001).   
 
2.5 Cell Transformation 
 Chemical cell transformations were performed based upon the rubidium chloride 
method by New England Biolabs, Inc.  Chemically competent cells were prepared by 
inoculating 5 mL of LB medium, supplemented with the appropriate antibiotics as 
specified in each experiment, with a single colony from an LB rich plate.  Cells were 
grown overnight in in an Excella E25 rotary shaker (New Brunswick Scientific, Enfield, 
CT) at 37°C and 250 rpm.  A volume of 0.5 mL of the overnight culture was used to 
inoculate 50 mL of LB supplemented with 20 mM MgSO4 and appropriate antibiotics.  
Subcultures were grown to OD600 values of approximately 0.4-0.6 and centrifuged at 
5,000 rpm for 5 minutes at 4 °C.  The pellet was gently resuspended in 20 mL ice cold 
TFBI (30 mM potassium acetate, 100 mM RbCl, 10 mM CaCl2, 50 mM MnCl2, and 15% 
glycerol, filter sterilized and pH adjusted to 5.8 with acetic acid), incubated on ice for 5 
minutes, and centrifuged once more at 5,000 rpm for 5 minutes at 4 °C.  The pellet was 
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gently resuspended in 2 mL ice cold TFBII (10 mM MOPS, 75 mM CaCl2, 10 mM RbCl, 
and 15% glycerol, filter sterilized and pH adjusted to 6.5 with KOH) and incubated on ice 
for 15-60 minutes.  Aliquots were prepared by pipetting 100 µL of the resuspended cells 
into 1.5 mL sterile centrifuge tubes and stored at -80°C.    
 Cells were transformed by taking an aliquot of chemically competent cells, 
thawing on ice, adding 1-1.5 µL of DNA, and incubating on ice for 30-60 minutes.  The 
mixture was heat shocked for 45 seconds at 37°C and incubated on ice for 2 minutes.  
Transformed cell suspensions were diluted into 1.4 mL LB with no antibiotics to allow 
for recovery and phenotypic expression.   Following cultivation in in an Excella E25 
rotary shaker (New Brunswick Scientific, Enfield, CT) at 37 °C and 250 rpm for 40-60 
minutes, transformed cells were plated on selective medium and grown overnight at 
37°C.     
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Chapter 3 
3.  Effects of Pyridine Nucleotide Transhydrogenases on the Production of  
(S)-2-chloropropionate in Escherichia coli 
 
3.1  Abstract 
 The syntheses of several industrially useful compounds are cofactor-dependent.  
Biocatalysis has emerged as a valuable tool for large-scale, industrial production 
processes as it is a cost-effective means of production, acting as both a catalyst and 
cofactor regenerator.  The reducing equivalent NADPH is required in several enzymatic 
reactions leading up to the synthesis of high-value compounds such as polymers, chiral 
alcohols, and antibiotics, to name a few.  However, it is a highly costly compound and its 
intracellular availability can oftentimes act as a limiting factor in product yield.  This 
study focuses on the genetic manipulation of a whole-cell system using the two 
transhydrogenase isoforms pntAB and udhA.  Escherichia coli strains are engineered to 
evaluate the effects of the two transhydrogenases on NADPH availability in order to 
increase the NADPH pool for improved production of products that require NADPH in 
their biosynthesis.  Recombinant E. coli strains containing pntAB and/or udhA deletion 
and/or pntAB or udhA overexpression were constructed.  Genetic manipulations and 
subsequent effects on NADPH availability were assessed using the following model 
system: the production of (S)-2-chloropropionate catalyzed by the NADPH dependent 2-
haloacrylate reductase (CAA43) under both aerobic and anaerobic conditions.  Results 
suggest that the presence of udhA increases product yield and NADPH availability while 
the presence of pntAB has the opposite effect.  A maximum product yield of 1.4 mole 
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product/mole glucose was achieved aerobically in a pntAB-deletion strain with udhA 
overexpression, a 150% improvement over the wild-type control strain.   
 
3.2  Introduction 
 As the fields of genetic and metabolic engineering have advanced over the years 
so have their applications in both industrial settings and academic institutions.  In 
particular, the implementation of biocatalysis for industrial purposes has gained 
considerable ground.  Biocatalysts are widely accepted as excellent means for large-scale, 
industrial chemical processes.  They exhibit regio- and sterio- specificities and call for 
mild culture conditions (Endo, 2001).   
Currently, most genetic and metabolic engineering studies place an emphasis on 
manipulating enzyme levels via the addition, amplification, and/or deletion of pathways.  
The majority of biocatalysts in use are cofactor-independent ones that carry out rather 
elementary chemical reactions, such as hydrolases (Zhao, 2003).  Cofactor-dependent 
enzymes, on the other hand, are capable of carrying out more complex chemistry and are 
known to catalyze an assortment of industrially-relevant reactions.  Oxidoreductases and 
transferases are two examples of industrially useful compounds, as they are able to 
catalyze several regio- and stereo- selective reactions for the synthesis of high purity 
chiral compounds.  However, the syntheses of these compounds are dependent upon low 
molecular weight, non-protein compounds known as cofactors, which play a role in 
several biochemical reactions.  Subsequently, cofactor level is an additional control 
parameter to consider and acts as supplemental tool when attempting to study and 
achieve specific metabolic engineering goals.   
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Some cofactors, like biotin and pyridoxal phosphate, are self-regenerating.  
Others, like pyridine nucleotides and nucleoside triphosphates, act as co-substrates and 
transfer agents that accept or donate functional groups (hydrides, phosphates, etc.) in an 
enzymatic reaction (Chenault, 1988).  Cofactors like these must be provided in 
stoichiometric quantities.  Reducing equivalent cofactors, like NADPH, are needed in 
several enzymatic reactions leading up to the synthesis of high-value compounds.  Chiral 
compounds, for instance, utilize NADPH and are common intermediates used in the 
production of pharmaceutical products, like the stereoselective synthesis of statins, a 
cholesterol-lowering drug (Panke, 2005).  Unfortunately, in spite of their utility, these 
cofactors are costly.  Their use in large-scale industrial settings is precluded by their high 
costs (Table 3.1).  In order to make these processes economically feasible, an effective 
regeneration system is needed.   
Table 3-1.  Average cost per gram mole of common  
cofactors (adapted from Chenault, 1988).   
Key: a) Kyowa Hakko Kogyo Co., Ltd.   
b) Sigma Chemical Co.   
c) United States Biochemical Corp. 
Cofactor $/g mol 
Acetyl CoA 1,300,000 
c 
CoA 249,000
 c 
ATP 220 
a 
NAD 710 
a 
NADH 3,100 
a 
NADP 25,800 
b 
NADPH 216,000 
b 
 
 Many cofactor regeneration systems have been studied in the past.  Four broad 
categories of pyridine cofactor regeneration have been previously described by Chenault 
et al. (1987) and are as follows: biological, enzymatic, electrochemical, and 
chemical/photochemical.  Chemical regeneration methods are rather straightforward, 
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commercially available, and cost effective.  However, they are marked by limited 
compatibility with enzymatic systems, low product yield, and slow rates.  
Electrochemical and photochemical regeneration methods utilize electrical or light 
energy as a driving force in the cofactor regeneration step, but again are characterized by 
limited compatibility with enzymatic systems, low selectivity, and poor selectivity.  
Enzymatic regeneration methods are further delineated and divided into two 
subcategories: substrate-coupled and enzyme-coupled.  In substrate-coupled enzyme 
regeneration systems, a single enzyme uses both the reduced and oxidized forms of a 
cofactor alongside two substrates and catalyzes both the main reaction of interest as well 
as the regeneration reaction.  Whereas in an enzyme-coupled regeneration system, two 
different enzymes and substrates are used, catalyzing the reaction of interest and the 
regeneration reaction (Wichmann, 2005).  The benefits of these enzymatic regeneration 
systems are their high selectivity, high compatibility with enzyme-catalyzed synthesis, 
and high reaction rates.  However, the use of isolated enzymes is not economically 
feasible, especially when multiple enzymatic steps are needed or when reactions call for 
large quantities of enzymes.  This method is quite costly, as it requires protein 
purification, external cofactor addition, and/or external co-substrate addition.  A more 
viable and cost-effective alternative is a biological regeneration method that utilizes 
whole cells or organelles that possess the desired enzyme activity.  Whole-cell systems 
present a more economically-feasible approach because they are, in essence, self-
assembling processes.  All of the required enzymes are produced by the organism by 
natural means or by heterologous expression (Schmid, 2001).   
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 Redox reactions have significant commercial utility, as they play a key role in the 
synthesis of industrially relevant compounds.  These reactions require intermediates and 
cofactors produced via cellular central metabolism.  Host organisms rely upon over 1,000 
anabolic reactions when synthesizing individual components essential to overall cell 
function and require cofactor pairs for product formation (Forster 2003).  Cofactors such 
as ATP, NADP, and NADPH, in particular, are of enormous importance for the synthesis 
of compounds such as antibiotics (Gunnarsson 2004), biopolymers (Sanchez 2006, Wong 
2008), and chiral alcohols (Hummel 1997), among others.   
 Cofactor pairs like NAD/NADP and NADH/NADPH are essential in these 
processes, as they are capable of reversible transformation between oxidized and reduced 
states and shuttle electrons in oxidation and reduction reactions.  However, because of 
demanding parameters such as expensive production costs and high cellular demand for 
reducing equivalents, industrial applications typically utilize whole-cell fermentation 
systems.  As mentioned previously, whole-cell systems offer a viable, cost-effective 
approach for supplying and regenerating cofactors, such as the reducing equivalent 
NADPH.  However, in spite of their utility, inherent regeneration rates can be a limiting 
factor for attaining high product yields and productivity (Gunnarsson 2004, San 2002).   
Additionally, when applying metabolic engineering design strategies, care must be taken 
to ensure that cofactors are supplied in stoichiometric quantities that allow for regulated, 
balanced growth.  
The oxidative branch of the pentose phosphate pathway (PP) and isocitrate 
dehydrogenase of the tricarboxylic acid cycle (TCA) cycle are the main two sources of 
NADPH (Fig. 3-1).  The pentose phosphate pathway is responsible for regenerating the 
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majority of NADPH from NADP
+
, where two units of the reduced cofactor are produced 
per glucose (Gunnarsson, 2004).  This work focuses on the application of rational genetic 
modifications using pathway and cofactor engineering to manipulate and characterize 
NADPH availability by determining product yields of cofactor-dependent products in 
Escherichia coli.  This objective is achieved using classic metabolic engineering 
strategies such as overexpression and deletion of specific enzymes, wherein whole-cell 
fermentation systems are implemented to allow for more robust and cost-effective 
compound synthesis.  Cofactor constraints are taken into consideration in efforts to attain 
high product yields and productivities when catalyzing the substrate to product 
conversions.   
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Figure 3-1.  Central carbon metabolic pathway of E. coli.  Primary NADPH-generating 
reactions are the oxidative step of the pentose phosphate (PP) pathway and the isocitrate 
dehydrogenase step in the TCA cycle.  Adapted from Sauer et al., 2004.   
 
Past studies have manipulated NADPH levels in order to assess productivity.  Lee 
et al. (2009) investigated cofactor effects on the production of thymidine, a 
commercially-relevant precursor commonly used in the synthesis of antiviral drugs, by 
overexpressing NADK, an intracellular NAD+ and NADP+ concentration regulator.  The 
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mutant strain increased NADPH levels by 1.3 fold and decreased NADP+ levels by 10%.  
The subsequent increase in the NADPH/NADP+ ratio resulted in a 1.2 fold increase in 
thymidine production.  Moreira dos Santos et al. (2004) added an additional source of 
NADPH into cells by overexpressing the malic enzyme in Saccharomyces cerevisiae, 
resulting in decreased pentose phosphate pathway flux and a net transhydrogenase effect, 
indicating potential for increasing NADPH production capacity.  Verho et al. (2003) 
facilitated NADPH regeneration in S. cerevisae by overexpressing the fungal NADP
+
-
dependent D-glyceraldehyde-3-phosphate dehydrogenase (NADP-GAPDH) from 
Kluyveromyces lactis, which was previously discovered to regenerate NADPH (Verho, 
2002).  NADPH levels have also been manipulated in E. coli by knocking out the 
phosphorglucosisomerase (pgi) gene.  Deletion of the pgi gene forces carbon flow 
through the pentose pathway, resulting in the overproduction of NADPH.  However, this 
overproduction was found to have a detrimental effect on cell growth (Canonaco 2001, 
Hanson 1980, Kabir 2003).   Lee et al. (2007) observed heightened production of ε-
caprolactone in recombinant E. coli strains expressing cyclohexane monooxygenase 
(CHMO) and the NADPH regenerating enzyme, glucose 6-phosphate dehydrogenase, 
encoded by the zwf gene in E. coli.  They achieved maximal ε-caprolactone 
concentrations of 15.3 g/L, a 39% improvement in comparison to the control strain (Lee, 
2007).  Sanchez et al. (2006) increased NADPH availability in E. coli by overexpressing 
the soluble pyridine nucleotide transhydrogenase, udhA, resulting in high yield and 
productivity of the biodegradable polymer, poly(3-hydroxybutyrate) (PHB).  They 
reported a significant increase in NADPH-dependent PHB production with a udhA 
overexpression strain.   
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Thus far, two types of pyridine nucleotide transhydrogenases have been 
documented in living organisms.  The energy-linked transhydrogenase, PntAB is a 
membrane-bound, proton-translocating transhydrogenase located in the mitochondria of 
heterotrophic and photosynthesizing bacteria.  While UdhA is a soluble, energy-
independent transhydrogenase found in some heterotrophic bacteria (Sauer 2004, 
Voordouw 1983).  Typically, only one transhydrogenase isoform or none altogether is 
inherently found in microorganisms.  The exception to this rule is the Enterobacteriaceae 
family, which encompasses E. coli and contains both transhydrogenase isoforms: PntAB 
and UdhA (Boonstra 1999, Clarke 1986, Sauer 2004).   These two isoforms are theorized 
to have a large role in maintaining redox balance within microorganisms.   
However, they are not thoroughly studied and their physiological role is not 
clearly understood.  Limited information on pyridine nucleotide transhydrogenases in E. 
coli is at our disposal.  Additionally, a consensus has yet to be reached regarding their 
unique roles and direction of the reaction they catalyze (Canonaco 2001, Chin 2008, 
Hansen 2005, Hanson 1980, Hoek 1988, Jackson 1998, Sanchez 2006, Sauer 2004).  The 
common line of thought marks the oxidative steps of the pentose phosphate pathway and 
the isocitrate dehydrogenase steps of the TCA cycle as the primary sources for generating 
NADPH (Sauer 2004).  Nevertheless, pyridine nucleotide transhydrogenases are also 
speculated to play an important role in modulating and maintaining the availability of 
reducing equivalents, like NADPH, within the cell.  Yet, as mentioned previously, since 
the discovery of transhydrogenases, their physiological role has yet to be clearly and 
definitively understood.   
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An early study by Hanson and Rose in 1980 created an insertion mutation in the 
pnt locus of E. coli cells and concluded that the transhydrogenase is not necessary for the 
production of NADPH or ATP in E. coli, as no significant changes in growth rate were 
observed when grown using a variety carbon sources.  In the same study, Hanson and 
Rose also constructed pnt mutant strains in both a glucose-6-phosphate-1-dehydrogenase 
(zwf) and a phosphoglucose isomerase (pgi) mutant background to examine the 
importance of the transhydrogenase in NADPH production.  Zwf is the first enzyme in the 
NADPH-generating pentose phosphate pathway while pgi is an NADPH-dependent gene 
involved in glycolosis.  When a single zwf mutant and a single pgi mutant were 
constructed, the pgi mutant exhibited lowered growth rate in comparison to the wild type 
strain while the zwf mutant’s growth rate was not significantly affected.  When the pnt 
mutation was introduced into these mutant backgrounds, the zwf mutant strain was found 
to have a significantly lower growth rate while the pgi mutant strain remained unchanged.  
The observed trends in growth rate suggest that pntAB is primarily involved in supplying 
NADPH.  This notion that pntAB acts as a major source for NADPH generation was also 
supported by studies by Sauer et al. (2004).  They reported that 35-45% of NADPH 
produced during aerobic growth on glucose was from pntAB, compared to 35-45% and 
20-25% via the pentose phosphate pathway and isocitrate dehydrogenase, respectively.   
The soluble transhydrogenase, udhA, was previously reported to have a prominent 
role under conditions where there is significant NADPH overproduction (Canonaco 2001, 
Sauer 2004).    Canonaco et al. (2001) examined the effects of udhA overexpression in 
pgi mutant E. coli strains.  As mentioned previously, deletion of the pgi gene blocks 
glycolytic breakdown of glucose and forces carbon flow through the pentose pathway, 
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resulting in excess NADPH production and a decline in NADH availability (Canonaco 
2001, Hanson 1980, Kabir 2003).  Pgi mutant strains are also marked by significantly 
reduced growth rates.  When coupled with udhA overexpression, Canonaco et al. reported 
partial growth rate restoration by approximately 25%.  This finding supports the 
hypothesis that the kinetic limitation in glucose catabolism in pgi mutants is partially due 
to insufficient reoxidation of NADPH.  Thus, the apparent function of udhA is the 
reduction of NAD+ to NADH using NADPH as an electron donor.  Complete recovery of 
growth was not observed in pgi mutants because the pentose pathway has limited 
capacity in comparison to the glycolosis-TCA cycle pathway in terms of cell growth 
(Canonaco, 2001).  Another study by Hansen and Schonheit (2005) examined a double 
mutant strain of E. coli lacking both the pgi and udhA genes.  This pgi-udhA mutant strain 
was unable to grow using glucose as its sole energy source, offering further support for 
the hypothesis that udhA is essential in the reoxidation of NADPH by reducing NAD+.   
As of now, only a handful of articles have examined the function of pyridine 
nucleotide transhydrogenases and their effects on the synthesis of cofactor-dependent 
products.  Chin et al. (2009) investigated the effects of transhydrogenase deletion and 
overexpression mutant strains on NADPH-dependent xylitol yield.  They reported no 
significant improvement in xylitol yield when pntAB and udhA were overexpressed in 
two separate strains with xylose reductase from Candida boidinii.  In fact, they noted an 
unexpected decrease in xylitol yield when pntAB was overexpressed.  Furthermore, 
pntAB, udhA, and pntAB-udhA deletions had no apparent effect on xylitol yield.  This 
finding is in contrast to a study performed by Weckbecker and Hummel (2004).  They 
examined NADPH-dependent production of (R)-phenylethanol from acetophenone in 
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alcohol dehydrogenase (ADH) and formate dehydrogenase (FDH) overexpressing E. coli 
cells.  The NADP+-dependent ADH from Lactobacillus kefir reduces acetophenone and 
was coupled with FDH from Candida boidinii, as it is an effective NADH regenerator.  
(R)-phenylethanol production was compared in an ADH-FDH overexpression strain and 
an ADH-FDH overexpression strain containing a pntAB overexpression cassette, which 
essentially acts as an NADPH and NAD+ regenerator (see Fig. 3-2).  (R)-phenylethanol 
production increased from 19% to 66% in the pntAB-overexpressing strain, supporting 
the notion that NADPH was the limiting factor in the reaction and that pntAB regenerated 
NADPH.  An additional study performed by Sanchez et al. (2006) overexpressed the 
soluble transhydrogenase, udhA, in E. coli and examined its subsequent effects on the 
yield and productivity of NADPH-dependent poly(3-hydroxybutyrate) (PHB).  This setup 
allowed them to study the effect of udhA when NADPH is in high demand.  They noted a 
significant increase in PHB yield and concentration, increasing from 49 to 66% and 3.52 
to 6.42 g/L, respectively.  This finding suggests that, in circumstances when there is 
significant NADPH drain such as in the synthesis of PHB, udhA favors the direction of 
NADPH production.  Thus, overexpression results in a greater NADPH pool (Chin 2009, 
Sanchez 2006).  A recent study by Lee et al. (2010) examined NADPH-dependent 
thymidine production by constructing a udhA-overexpressing strain in a pgi deletion 
background.  When compared to the control strain, thymidine production increased 2-fold 
with udhA overexpression.  Furthermore, they measured expression levels of redox-
related enzymes in pgi mutant strains with either udhA or yfjB (NAD+ kinase; NADK) 
overexpression.  NADK generates a NADP+ pool from NAD+ in E. coli.  They found 
that NADK overexpression increased intracellular redox equivalent levels significantly, 
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accompanied by higher transhydrogenase expression levels (pntAB and udhA) in order to 
maintain intracellular redox balance.  Both NADPH and NADP+ levels were increased in 
this instance.  Contrastingly, in udhA overexpression, intracellular redox equivalent levels 
were only moderately increased and were accompanied by elevated NADPH and lower 
NADP+ levels.  In this respect, udhA overexpression had a significant effect on the 
intracellular NADPH/NADP+ ratio, contributing to enhanced thymidine production.  The 
authors suggest that udhA elevates NADPH availability in an indirect manner by reducing 
the metabolic burden on the cell and modulating a favorable NADH and NADPH 
distribution.     
 
Figure 3-2.  An (R)-phenylethanol production system coupling alcohol dehydrogenase 
(ADH), formate dehydrogenase (FDH), and the membrane-bound transhydrogenase 
pntAB for the regeneration of reducing equivalents.  Adapted from Weckbecker and 
Hummel, 2004.   
 
45 
 
 
Evidently, we have yet to achieve a thorough understanding in regards to the roles 
associated with the two transhydrogenase isoforms in E. coli.  As a whole, literature 
sources suggest that pntAB drives the transfer of reducing power from NADH to NADP+ 
while udhA favors the transfer of reducing power from NADPH to NAD+ (Fig. 3-3).  
Yet, reports suggest that both isoforms are capable of catalyzing the opposite reaction 
depending upon culture conditions, environmental perturbations, and genotype.  
Additionally, as the two isoforms are involved in maintaining the redox balance between 
NADPH and NADH, the deletion and/or overexpression of one or the other has been 
hypothesized to relieve burdens/limitations posed upon cofactors, resulting in higher 
yields in NADPH-dependent product synthesis reactions.    In order to gain a better 
understanding about the roles and underlying mechanisms of the two isoforms on 
cofactor availability to enhance NADPH-dependent productivity, additional research is 
needed.   
 
 
Figure 3-3.  Proposed mechanism for NADPH 
   shuffling by the two transhydrogenase isoforms 
   udhA and pntAB.  Adpated from Sauer et al. (2003). 
 
In this study, we examine the effects of two transhydrogenases (PntAB and UdhA) 
on NADPH availability.  PntAB, a membrane-bound, proton-translocating 
transhydrogenase, and UdhA, a soluble, energy-independent transhydrogenase, function 
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in NADPH metabolism of E. coli (Sauer 2004).  These two transhydrogenease isoforms 
transfer electrons between NAD and NADP in accordance with the following equation: 
 + 

↔	

+ . 
Genetic manipulations and subsequent effects on NADPH availability were 
assessed using the following model system: the production of (S)-2-chloropropionate 
catalyzed by the NADPH dependent 2-haloacrylate reductase (CAA43).  The CAA43 
gene encoding the enzyme 2-haloacrylate reductase, which catalyzes the NADPH-
dependent reduction of the carbon-carbon double bond in 2-chloroacrylate, was first 
discovered by Kurata et al. (2005) and has been cloned and expressed in Escherichia coli 
from its native host Burkholderia sp. WS, a soil bacterium (Kurata 2005, 2008).  The 
production of (S)-2-chloropropionate from 2-chloroacrylate was chosen as a model 
system for monitoring NADPH availability because 2-haloacrylate reductase, the enzyme 
catalyzing the one-step conversion to (S)-2-chloropropionate in the synthesis pathway 
(Fig. 3-4), requires NADPH as a cofactor.  In the following studies, E. coli strains were 
transformed with the appropriate plasmids encoding transhydrogenase gene deletions 
and/or overexpressions, cultured, and assayed for product formation and NADPH 
availability.   
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Figure 3-4.  Pathway for the degradation of 2-chloroacrylate to (S)-2-chloropropionate, 
catalyzed by the enzyme 2-haloacrylate reductase (CAA43).  Adapted from Kurata et al., 
2005.     
 
3.3  Materials and methods 
3.3.1  Bacterial strains and plasmids 
The strains and plasmids used in this study are described in Table 3-2, below.  
Wild type (MG1655), single udhA (MBS601) and pntAB (MBS602) transhydrogenase 
mutants, and a double transhydrogenase mutant (MBS603) were transformed with 
plasmids pCAA43, containing the 2-haloacrylate reductase gene, and either pPNTAB 
carrying the pntAB gene or pUDHAC carrying the udhA gene.  pDHC29 was used as a 
control.  Construction of these strains is described in detail in section 2.1.2 of the 
Materials and Methods chapter. 
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Table 3-2.  List of E. coli strains and plasmids used in this study. 
 Genotype References 
Strain   
MG1655 Wild type E. coli (F
-
 λ
-
) ATCC 47076 
MBS601 MG1655 ∆udhA This study 
MBS602 MG1655 ∆pntAB This study 
MBS603 MG1655 ∆pntAB ∆udhA This study 
Plasmids   
pDHC29 Cloning vector, Cm
R
 (Phillips et al. 2000) 
pCAA43 2-Haloacrylate reductase 
gene from Burkholderia sp. 
in pTrc99A, Amp
R
  
(Kurata et al.  2005) 
pPNTAB Proton-translocating 
pyridine nucleotide 
transhydrogenase gene 
(pntAB) from E. coli, in 
pDHC29, Cm
R 
This study 
pUDHAC Soluble pyridine nucleotide 
transhydrogenase gene 
(udhA) from E. coli in 
pDHC29, Cm
R
 
This study 
 
 
3.3.2  Cultivation medium 
Chemicals used in the following procedures were purchased from Sigma-Aldrich 
(St. Louis, MO), unless denoted otherwise. 
 
3.3.2.1  LB medium 
 Luria-Bertani (LB) broth medium contained 10 g/L tryptone (Amresco, Solon, 
OH), 5 g/L yeast extract (BD Biosciences, Franklin Lakes, NJ) and 10 g/L NaCl.  The LB 
medium was autoclaved at 121°C for 20-35 minutes, depending upon the volume of 
liquid being autoclaved.  After autoclaving, glucose, antibiotics, and other various 
compounds were added aseptically as need be in accordance with each experiment.   
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 For aerobic and anaerobic (S)-2-chloropropionate production shake flask 
experiments, antibiotics were added at concentrations of 100 mg/L ampicillin and 35 
mg/L chloramphenicol for strain selection and plasmid stability.  The LB medium used 
was supplemented with 1% glucose as specified in experimental procedures.  (Kurata 
2005, Kurata 2008) 
 
3.3.2.2  Defined medium 
 M9 minimal growth medium contains 6 g/L Na2HPO4, 3 g/L KH2PO4, 0.5 g/L 
NaCl.  CaCl2, MgSO4, and Vitamin B1 (thiamine) were added to the medium after 
autoclaving to final concentrations of 1 mM, 0.1 mM, and 1 µg/mL, respectively.  The 
medium was supplemented with 100 mg/L ampicillin, 35 mg/L chloramphenicol, and 2% 
glucose unless indicated otherwise.      
 
3.3.3  Cultivation conditions  
3.3.3.1  Cultivation conditions in LB medium 
 Cultures for (S)-2-chloroproprionate production experiments were performed 
using 500 mL shake flasks containing 150 mL of LB media containing the appropriate 
antibiotics.  No glucose was present in the medium a carbon source.  Cultures were 
inoculated with 1.5 mL (1% v/v) of the overnight culture.  After inoculation cells were 
grown in an Excella E25 rotary shaker (New Brunswick Scientific, Enfield, CT) at 30 °C 
and 250 rpm.  When the optical density at 600 nm reached approximately 0.5, isopropyl-
1-thio-β-D-galactopyranoside (IPTG) was added to a final concentration of 1 mM to the 
medium.  Cells were cultivated in an Excella E25 rotary shaker (New Brunswick 
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Scientific, Enfield, CT)at 30 °C and 250 rpm for approximately 18 hours in the presence 
of IPTG prior to being harvested for the production of (S)-2-chloroproprionate under 
aerobic and anaerobic conditions.   
 
3.3.3.2  Cultivation conditions in defined medium 
 Aerobic shake flask experiments were performed using 250 mL shake flasks 
containing 20 mL of defined M9 media.  2-chloroacrylate was added to the medium to a 
final concentration of 50 mM and the mixture was pH adjusted to 7.0 with 6 N HCl.  
Cultured cells were harvested by centrifugation, washed, and resuspended in the reaction 
medium to a final concentration of approximately 10 OD600 to monitor the degradation of 
2-chloroacrylate into (S)-2-chloropropionate.  A volume of 20 mL of resuspended culture 
was transferred aseptically to each flask.  Flasks were capped with foam stoppers.  The 
reaction was carried out in in an Excella E25 rotary shaker (New Brunswick Scientific, 
Enfield, CT) at 37 °C and 250 rpm.  Samples of the cultures were taken at 0 and 6 hours 
and analyzed for (S)-2-chloropropionate and extracellular metabolite production. 
 Anaerobic shake tube experiments were performed using 15 mL amber-colored 
glass tubes containing 14.5 mL of defined M9 media.  2-chloroacrylate was added to the 
medium to a final concentration of 50 mM and the mixture was pH adjusted to 7.0 with 6 
N HCl.  Cultured cells were harvested by centrifugation, washed, and resuspended in the 
reaction medium to a final concentration of approximately 10 OD600 to monitor the 
degradation of 2-chloroacrylate into (S)-2-chloropropionate.  A volume of 14.5 mL of 
resuspended culture was transferred aseptically to each tube to ensure anaerobic 
conditions.  Tubes were capped with a rubber septum.  The reaction was carried out in in 
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an Excella E25 rotary shaker (New Brunswick Scientific, Enfield, CT) at 37 °C and 250 
rpm.  Samples of the cultures were taken at 0 and 6 hours and analyzed for (S)-2-
chloropropionate and extracellular metabolite production. 
 
3.3.4  Inoculum preparation and conditions for (S)-2-chloropropionate experiments 
For each experiment, wild-type, single udhA and pntAB transhydrogenase 
mutants, and the double transhydrogenase mutant were freshly transformed with the 
pCAA43 plasmid and appropriate overexpression or control plasmids.  A single colony 
was restreaked onto a plate containing 100 mg/L ampicillin and 35mg/L 
chloramphenicol.  A single colony was transferred into 3 mL LB supplemented with 100 
mg/L ampicillin, 35mg/L chloramphenicol, and 1% glucose and grown overnight 
aerobically at 37°C and 250 rpm in an Excella E25 rotary shaker (New Brunswick 
Scientific, Enfield, CT).  Cells were inoculated at 1% v/v into 500 mL shake flasks 
containing 150 mL of LB media supplemented with 100 mg/L ampicillin and 35mg/L 
chloramphenicol.  No glucose was present in the medium a carbon source.  Flasks were 
grown aerobically at 37°C and 250 rpm.   
 
3.3.5  Analytical techniques 
 Cell density (OD) was taken at 600nm in a DU 800 spectrophotometer (Beckman 
Coulter, Irving, TX).  Culture samples were diluted, as appropriate, with LB medium to 
maintain readings in the linear range of the spectrophotometer (0.1-0.4 OD600).   
 In order to quantify extracellular metabolites, 1 mL of the fermentation broth was 
sampled and centrifuged at 13,000 g for 3 minutes in a microcentrifuge.  The supernatant 
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was filtered through a 0.2 µm PTFE syringe filter and stored frozen for HPLC analysis.  
A Shimadzu-10A HPLC System (Shimadzu Scientific Instruments, Columbia, MD) 
equipped with a cation-exchange column (HPX-87H, BioRad Labs, Hercules, CA), a UV 
detector (Shimadzu SPD-10A), and a differential refractive index detector, RI, (Waters, 
Milford, MA) was used to detect extracellular metabolites such as glucose, succinate, 
lactate, and acetate, among others.  A solution of 2.5 mM H2SO4 was used as the mobile 
phase and operated at a0.5 mL/min flow rate.  The column was operated at 55°C.   
 
3.4  Results and discussion 
3.4.1  Aerobic (S)-2 chloropropionate production experiment results 
Aerobic shake flask experiments were performed with mutant and control strains 
in defined M9 medium utilizing glucose as the carbon source to evaluate 
transhydrogenase effects on NADPH availability.  Mutant E. coli strain cell growth was 
comparable to the control, indicating limited growth impairment with the exception of the 
pntAB deletion strains (MBS602 pCAA43 pDHC29, MBS602 pCAA32 udhA) (Fig. 3-5).   
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Figure 3-5.  Cell growth of control (MG1655 pCAA43 pDHC29) and modified E. coli 
strains (MBS601, ∆udhA; MBS602, ∆pntAB; MBS603, ∆pntAB∆udhA) under aerobic 
conditions in LB medium with IPTG induction for 18 hours at 30°C and 250 rpm.    
 
Three mutant background strains were evaluated against a control strain 
(MG1655), each containing the 2-haloacrylate reductase gene (pCAA43) and the empty 
control vector pDHC29.  All three mutant strains exhibited higher product yield than the 
control (Table 3-3).  The mutant strain MBS602 pCAA43 pDHC29 had a significant 
boost in product yield over the control strain, producing 2.2 times that of the control (1.25 
compared to 0.571 mole (S)-2 chloroproprionate/mole glucose).  One mole of NADPH is 
consumed per mole of (S)-2 chloropropionate produced (Fig. 3-4).  Therefore, this 
mutant strain produced 120% more NADPH than the control strain.  The mutant strain 
MBS603 pCAA43 pDHC29 produced 1.41 times that of the control with 42% more 
NADPH, and the mutant strain MBS601 pCAA43 pDHC29 produced 1.3 times that of 
the control with 27% more NADPH.   
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Table 3-3.  Production of (S)-2 chloropropionate in shake flasks under aerobic conditions 
by E. coli strains with wild-type and mutant backgrounds in defined M9 medium using 
glucose as the energy source where (+) denotes transhydrogenase expression and (-) 
denotes transhydrogenase deletion.  Data shown are averages of triplicate experiments.  
Strain 
Yield 
(mole product/mole glucose) 
Glucose 
Consumption 
MG1655 pCAA43 pDHC29 
udhA+ pntAB+ 
0.5707 ± 0.0163 41.00 ± 1.058 
MBS601 pCAA43 pDHC29 
udhA- pntAB+ 
0.7271 ± 0.0079 42.23 ±  0.8095 
MBS602 pCAA43 pDHC29 
udhA+ pntAB- 
1.252 ± 0.0669 11.59 ±  0.7369 
MBS603 pCAA43 pDHC29 
udhA- pntAB- 
0.8075 ± 0.0408 42.71 ± 1.113 
 
When examining the effect of pntAB expression in the presence of udhA it is 
apparent that the increasing levels of pntAB decrease product yield.  Of the three udhA-
expressing strains shown in Table 3-4, the pntAB overexpression (pntAB++) strain has the 
lowest product yield.  Both product yield and NADPH levels increase by 10% in the 
udhA+ pntAB+ strain (MG1655 pCAA43 pDHC29) in comparison to the pntAB 
overexpression strain.  Furthermore, when pntAB is removed from the strain altogether 
(pntAB-), both product yield and NADPH levels are maximized in this set of strains.  An 
improvement of 140% and 120% is observed over the pntAB overexpression and the 
pntAB expression strains, respectively.  The presence of pntAB evidently decreases 
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product yield, with decreasing product yield observed with increasing pntAB expression 
levels.   
Table 3-4.  Production of (S)-2 chloropropionate in E. coli shake flask experiments under 
aerobic conditions in udhA-expressing strains with varying degrees of pntAB expression 
in defined M9 medium using glucose as the energy source where (+) denotes 
transhydrogenase expression, (-) denotes transhydrogenase deletion, and (++) denotes 
transhydrogenase overexpression.  Data shown are averages of triplicate experiments. 
Strain 
Yield 
(mole product/mole glucose) 
Glucose 
Consumption 
MG1655 pCAA43 pntAB 
udhA+ pntAB++ 
0.5191 ± 0.0112 40.54 ± 0.4648 
MG1655 pCAA43 pDHC29 
udhA+ pntAB+ 
0.5707 ± 0.0163 41.00 ±  1.0581 
MBS602 pCAA43 pDHC29 
udhA+ pntAB- 
1.252 ± 0.0669 11.59 ±  0.7369 
 
When examining the effect of pntAB expression in the absence of udhA, a similar 
though less pronounced trend is observed (Table 3-5).  Product yield and NADPH levels 
are boosted by 11% upon pntAB deletion, increasing from 0.727 mole product/mole 
glucose to 0.808 mole product/mole glucose.  These results mirror those presented 
earlier, indicating that the presence of pntAB decreases product yield.  When looking at 
the effects of pntAB deletion in both a udhA-deletion (MBS603 pCAA43 pDHC29) and 
udhA-expressing strain (MBS602 pCAA43 pDHC29), we note that a greater product 
yield is achieved in the udhA-expressing strain (1.25 vs. 0.808 mole product/mole 
glucose), suggesting that the presence of udhA may be beneficial in supplying NADPH 
for the production of (S)-2-chloropropionate.   
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Table 3-5.  Production of (S)-2 chloropropionate in E. coli shake flask experiments under 
aerobic conditions in udhA-knockout strains with varying degrees of pntAB expression in 
defined M9 medium using glucose as the energy source where (+) denotes 
transhydrogenase expression and (-) denotes transhydrogenase deletion.  Data shown are 
averages of triplicate experiments. 
Strain 
Yield 
(mole product/mole glucose) 
Glucose 
Consumption 
MBS601 pCAA43 pDHC29 
udhA- pntAB+ 
0.7271 ± 0.0079 42.23 ±  0.8095 
MBS603 pCAA43 pDHC29 
udhA- pntAB- 
0.8075 ± 0.0408 42.71 ± 1.113 
 
 The effects of varying levels of udhA expression are elucidated in the following 
set of strains with pntAB deletion presented in Table 3-6.  In the absence of both pntAB 
and udhA, product yield is lowest and increases by 55% to 1.25 mole product/mole 
glucose with udhA expression.  A maximum yield of 1.44 mole product/mole glucose 
consumed is achieved with udhA overexpression in a pntAB knockout background, a 15% 
and 79% increase over the udhA-expressing and udhA-deletion strains.  These results 
indicate that the presence of udhA has a positive effect on product yield.  Therefore, it 
appears that NADPH availability is udhA limiting under aerobic conditions.   
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Table 3-6.  Production of (S)-2 chloropropionate in E. coli shake flask experiments under 
aerobic conditions in pntAB-knockout strains with varying degrees of udhA expression in 
defined M9 medium using glucose as the energy source where (+) denotes 
transhydrogenase expression, (-) denotes transhydrogenase deletion, and (++) denotes 
transhydrogenase overexpression.  Data shown are averages of triplicate experiments. 
Strain 
Yield 
(mole product/mole glucose) 
Glucose 
Consumption 
MBS603 pCAA43 pDHC29 
pntAB- udhA- 
0.8075 ± 0.0408 42.71 ± 1.113 
MBS602 pCAA43 pDHC29 
pntAB- udhA+ 
1.252 ± 0.0669 11.59 ±  0.7369 
MBS602 pCAA43 udhA 
pntAB- udhA++ 
1.442 ± 0.0684 7.189 ±  0.3529 
 
 Complementation strains using single deletion background strains such as 
MBS601 and MBS602 presented a challenge due to issues with plasmid stability and cell 
growth.  Complementation strains using a double deletion background (MBS603) 
coupled with either udhA or pntAB expression plasmids were more viable.  However, 
results obtained with the two constructed complementation strains (MBS603 pCAA43 
udhA, MBS603 pCAA43 pntAB) fell short of those obtained with single deletion strains, 
due to a lack of knowledge on factors such as gene dosage, gene expression, etc (Table 3-
6).   
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Table 3-7.  Production of (S)-2 chloropropionate in E. coli shake flask experiments under 
aerobic conditions in complementation strains in defined M9 medium using glucose as 
the energy source where (+) denotes transhydrogenase expression and (-) denotes 
transhydrogenase deletion.  Data shown are averages of triplicate experiments. 
Strain 
Yield 
(mole product/mole glucose) 
Glucose 
Consumption 
MBS603 pCAA43 udhA 
udhA+ pntAB- 
0.9252 ± 0.0057 39.41 ± 0.5493 
MBS602 pCA43 pDHC29 
udhA+ pntAB- 
1.252 ± 0.0669 11.59 ±  0.7369 
MBS603 pCAA43 pntAB 
udhA- pntAB+ 
0.2151 ± 0.0023 40.87 ± 0.3646 
MBS601 pCAA43 pDHC29 
udhA- pntAB+ 
0.7271 ± 0.0079 42.23 ±  0.8095 
 
 The results of the (S)-2 chloroproprionate system evaluated under aerobic 
conditions at 37°C and 250 rpm in defined M9 medium showed that the presence of udhA 
in mutant E. coli strains expressing the 2-haloacrylate reductase gene catalyzing the 
NADPH-dependent reduction of 2-chloroacrylate to (S)-2 chloropropionate increases 
NADPH availability that can, in turn, be used to increase the yield of NADPH-dependent 
products.  Product yield is greatest in a single pntAB deletion strain with udhA 
overexpression, resulting in a 150% increase in NADPH-dependent production of (S)-2 
chloropropionate over the wild-type control strain (MG1655 pCAA43 pDHC29) from 
0.571 mole product/mole glucose to 1.44 mole product/mole glucose.  Additionally, 
when udhA is expressed in a clean background lacking both inherent pntAB and udhA 
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(MBS603 pCAA43 udhA), product yield is 62% greater than the wild-type control strain 
and 6.9% greater than udhA overexpression strain in a wild-type background (MG1655 
pCAA43 udhA).  Similar to findings by Lee et al. (2010) and Sanchez et al. (2006), these 
results suggest that udhA overexpression has a positive effect on product per glucose 
yield.    
 Contrastingly, mutant strains overexpressing pntAB had the lowest observed 
product yields.  Product yield suffered most in a pntAB-udhA mutant strain 
overexpressing pntAB (MBS603 pCAA43 pntAB) and was 62% lower than the wild-type 
control strain (0.215 mole product/mole glucose vs. 0.571 mole product/mole glucose).  
A slight drop in product yield occurred when pntAB was overexpressed in a wild-type 
background, decreasing by 9.1% compared to the control (0.519 mole product/mole 
glucose vs. 0.571 mole product/mole glucose).  These findings suggest that pntAB 
erexpression, particularly in the absence of udhA, has a detrimental effect on NADPH-
dependent product yield and NADPH availability in the presence of an electron sink.   
When inherent pntAB expression is accompanied by udhA deletion (MBS601) in 
aerobic conditions, a higher product yield is still achieved, though at a fraction of the 
amount when udhA expression is accompanied by pntAB deletion (MBS602) (Table 3-4 
and Table 3-5), suggesting that udhA expression has a more prominent role in NADPH 
generation in the presence of an electron sink.  Interestingly, a double deletion strain 
containing neither of the two transhydrogenase isoforms produced 42% more product 
than the control strain, indicating a greater NADPH pool in the absence of both pntAB 
and udhA.   
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 In summary, aerobic (S)-2 chloropropionate production experiments suggest that, 
in the presence of an electron sink, the soluble, energy-independent transhydrogenase 
udhA has a greater effect on driving NADPH regeneration in whole cell biocatalysis.  
Furthermore, pntAB overexpression reduces the NADPH pool.   
 
3.4.2  Anaerobic (S)-2-chloropropionate production experiment results 
Anaerobic shake tube experiments were performed with mutant and control 
strains in defined M9 medium utilizing glucose as the carbon source.  Mutant E. coli 
strain cell growth was comparable to the control, indicating limited growth impairment 
with the exception of the pntAB deletion strain (MBS602 pCAA43 pDHC29) (Fig. 3-6).   
 
Figure 3-6.  Cell growth of control (MG1655 pCAA43 pDHC29) and modified E. coli 
strains (MBS601, ∆udhA; MBS602, ∆pntAB; MBS603, ∆pntAB∆udhA) under aerobic 
conditions in LB medium with IPTG induction for 18 hours at 30°C and 250 rpm, 
subcultured into the anaerobic shake tubes.    
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When evaluating the three mutant background strains against the control in an 
anaerobic environment, a trend similar to the aerobic (S)-2 chloropropionate production 
experiments was observed.  However, only two of the three mutant strains exhibited 
higher product yield than the control, with the single udhA knockout strain being the 
exception (Table 3-8).  The single pntAB knockout strain (MBS602) had the highest 
yield, followed by the double deletion (MBS603) and single udhA knockout strain 
(MBS601).  MBS602 produced 1.9 times (S)-2 chloropropionate than the control with 
90.9% more NADPH.  MBS603 produced 1.4 times (S)-2 chloropropionate and 38% 
more NADPH than the control.  In contrast to the aerobic (S)-2 chloropropionate 
production experiments, the udhA knockout strain (MBS601) did have a higher product 
yield in comparison to the control.  Rather, product yield dropped by 20%, from 0.552 
mole product/mole glucose to 0.440 mole product/mole glucose.  
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Table 3-8.  Production of (S)-2 chloropropionate in anaerobic shake tubes by E. coli 
strains with wild-type and mutant backgrounds in defined M9 medium using glucose as 
the energy source  where (+) denotes transhydrogenase expression and (-) denotes 
transhydrogenase deletion.  Data shown are averages of triplicate experiments. 
Strain 
Yield 
(mole product/mole glucose) 
Glucose 
Consumption 
MG1655 pCAA43 pDHC29 
udhA+ pntAB+ 
0.552 ± 0.0164 31.87 ± 0.6574 
MBS601 pCAA43 pDHC29 
udhA- pntAB+ 
0.440 ± 0.0006 29.54 ±  0.0873 
MBS602 pCAA43 pDHC29 
udhA+ pntAB- 
1.054 ± 0.0519 8.337 ±  0.7994 
MBS603 pCAA43 pDHC29 
udhA- pntAB- 
0.763 ± 0.0260 15.52 ± 1.035 
 
Similar to the aerobic (S)-2 chloropropionate production results, increasing levels 
of pntAB decrease product yield in udhA-expressing strains (Table 3-9).  The pntAB 
overexpression (pntAB++) strain has the lowest product yield.  Both product yield and 
NADPH levels increase by 52% in the udhA+ pntAB+ strain (MG1655 pCAA43 
pDHC29) in comparison to the pntAB overexpression strain.  Furthermore, when pntAB is 
removed from the strain altogether (pntAB-), both product yield and NADPH levels are 
maximized in this set of strains to 1.05 mole product/mole glucose.  This pntAB deletion 
strain improves both product yield and the NADPH pool by 190% and 91% over the 
pntAB overexpression and the pntAB expression strains, respectively.  The presence of 
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pntAB evidently decreases product yield, with decreasing product yield observed with 
increasing pntAB expression levels. 
Table 3-9.  Production of (S)-2 chloropropionate in E. coli shake flask experiments under 
anaerobic conditions in udhA-expressing strains with varying degrees of pntAB 
expression in defined M9 medium using glucose as the energy source where (+) denotes 
transhydrogenase expression, (-) denotes transhydrogenase deletion, and (++) denotes 
transhydrogenase overexpression.  Data shown are averages of triplicate experiments. 
Strain 
Yield 
(mole product/mole glucose) 
Glucose 
Consumption 
MG1655 pCAA43 pntAB 
udhA+ pntAB++ 
0.3626 ± 0.0004 28.66 ± 0.1711 
MG1655 pCAA43 pDHC29 
udhA+ pntAB+ 
0.5522 ± 0.0164 31.87 ± 0.6574 
MBS602 pCAA43 pDHC29 
udhA+ pntAB- 
1.054 ± 0.0519 8.337 ±  0.7994 
 
When examining the effect of pntAB expression in the absence of udhA, a similar though 
less pronounced trend is observed (Table 3-10).  Product yield and NADPH levels are 
boosted 73% upon pntAB deletion, increasing from 0.440 mole product/mole glucose to 
0.763 mole product/mole glucose.  These findings support the previous conclusion that 
pntAB overexpression has a detrimental effect on NADPH-dependent product yield and 
NADPH availability in the presence of an electron sink and is more pronounced in the 
absence of udhA expression.  However, when comparing the effects of pntAB deletion in 
both a udhA-deletion (MBS603 pCAA43 pDHC29) and udhA-expression strain (MBS602 
pCAA43 pDHC29), we note that a greater product yield is achieved in the udhA-
expressing strain (1.05 vs. 0.763 mole product/mole glucose), suggesting that the 
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presence of udhA may be beneficial in supplying NADPH for the production of (S)-2-
chloropropionate.   
Table 3-10.  Production of (S)-2 chloropropionate in E. coli shake flask experiments 
under anaerobic conditions in udhA-knockout strains with varying degrees of pntAB 
expression in defined M9 medium using glucose as the energy source where (+) denotes 
transhydrogenase expression and (-) denotes transhydrogenase deletion.  Data shown are 
averages of triplicate experiments. 
Strain 
Yield 
(mole product/mole glucose) 
Glucose 
Consumption 
MBS601 pCAA43 pDHC29 
udhA- pntAB+ 
0.4402 ± 0.0006 29.54 ±  0.0873 
MBS603 pCAA43 pDHC29 
udhA- pntAB- 
0.7628 ± 0.0260 15.52 ± 1.035 
 
 The effects of varying levels of udhA expression are examined more closely in the 
following set of strains with pntAB deletion (Table 3-11).  In a double mutant background 
lacking both pntAB and udhA, product yield is lowest.  In contrast to results obtained 
under aerobic conditions, udhA overexpression does not produce the maximal product 
yield.  Instead, a pntAB deletion background strain with udhA expression (MBS602 
pCAA43 pDHC29) has the greatest product yield (1.054 mole product/mole glucose) , 
only slightly above that of the udhA overexpression strain (MBS602 pCAA43 udhA).  In 
fact, there is no significant difference in product yield of these two strains within error   
(P > 0.05, see Appendix).  .  These results deviate from those obtained under aerobic 
cultivation conditions.  While they still suggest that the presence of udhA has a positive 
effect on product yield, it appears that (S)-2chloroproprionate production is not udhA 
limiting.  Rather, NADPH availability is NADH limiting due to the fact that anaerobic 
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cellular metabolism cannot produce NADH via the TCA cycle as observed under aerobic 
conditions.   
Table 3-11.  Production of (S)-2 chloropropionate in E. coli shake flask experiments 
under anaerobic conditions in pntAB-knockout strains with varying degrees of udhA 
expression in defined M9 medium using glucose as the energy source where (+) denotes 
transhydrogenase expression, (-) denotes transhydrogenase deletion, and (++) denotes 
transhydrogenase overexpression.  Data shown are averages of triplicate experiments. 
Strain Yield 
(mole product/mole glucose) 
Glucose 
Consumption 
MBS603 pCAA43 pDHC29 
pntAB- udhA- 
0.763 ± 0.0260 15.52 ± 1.035 
MBS602 pCAA43 udhA 
pntAB- udhA++ 
1.016 ± 0.0441 6.116 ±  0.9355 
MBS602 pCAA43 pDHC29 
pntAB- udhA+ 
1.054 ± 0.0519 8.337 ±  0.7994 
 
 Complementation strains using single deletion background strains such as 
MBS601 and MBS602 presented a challenge due to issues with plasmid stability and cell 
growth.  Complementation strains using a double deletion background (MBS603) 
coupled with either udhA or pntAB expression plasmids were more viable.  However, 
results obtained with the two constructed complementation strains (MBS603 pCAA43 
udhA, MBS603 pCAA43 pntAB) fell short of those obtained with single deletion strains, 
due to a lack of knowledge on factors such as gene dosage, gene expression, etc (Table 3-
12).   
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Table 3-12.  Production of (S)-2 chloropropionate in E. coli shake flask experiments 
under anaerobic conditions in complementation strains in defined M9 medium using 
glucose as the energy source where (+) denotes transhydrogenase expression and (-) 
denotes transhydrogenase deletion.  Data shown are averages of triplicate experiments. 
Strain 
Yield 
(mole product/mole glucose) 
Glucose 
Consumption 
MBS603 pCAA43 udhA 
udhA+ pntAB- 
0.724 ± 0.0316 24.30 ± 0.9975 
MBS602 pCA43 pDHC29 
udhA+ pntAB- 
1.054 ± 0.0519 8.337 ±  0.7994 
MBS603 pCAA43 pntAB 
udhA- pntAB+ 
0.150 ± 0.0062 27.78 ± 0.7222 
MBS601 pCAA43 pDHC29 
udhA- pntAB+ 
0.440 ± 0.0006 29.54 ±  0.0873 
 
The metabolic role of the two transhydrogenase isoforms pntAB and udhA is still 
a matter of debate and is largely dependent upon the experimental conditions used (Chin 
2009, Hua 2003, Lee 2010, Sanchez 2006, Sauer 2004).  The mutant strains used in both 
the aerobic and anaerobic (S)-2 chloropropionate experiments in this study followed 
highly similar trends and suggest that, in the presence of an electron sink, the soluble, 
energy-independent transhydrogenase udhA has a greater effect on driving NADPH 
regeneration in whole cell biocatalysis and that pntAB overexpression reduces the 
NADPH pool.   
Overexpressing udhA increased product yield per glucose significantly while 
pntAB overexpression had the opposite effect (Fig. 3-7).  Thus, similar to a study by Chin 
67 
 
 
et al. (2009), it appears that pntAB does not readily transfer reducing equivalents from 
NADH to NADPH in the given system.  This finding is in contrast to a study performed 
by Weckbecker and Hummel (2004), wherein pntAB overexpression increased (R)-
phenylethanol production from 19% to 66%, suggesting sufficient NADPH regeneration 
via pntAB.  Weckbecker and Hummel evaluated NADPH supply by coupling three 
enzymatic reactions incorporating the NAD+-dependent formate dehydrogenase, wherein 
formate acted as the source of reducing equivalents and could produce one (R)-
phenylethanol per formate consumed.  It appears that, given a one-step system with an 
electron sink, pntAB is not a major source of NADPH and is, in fact detrimental to 
NADPH regeneration as evidenced by the significant increase in (S)-2chloropropionate 
yield per glucose in both aerobic and anaerobic conditions over the control.  (S)-2 
chloropropionate yields with udhA overexpression increased significantly, supporting 
reported results by Lee et al. (2010) and Sanchez et al. (2006) and suggesting increased 
NADPH availability due to udhA overexpression.   
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Figure 3-7.  Aerobic and anaerobic product yield per glucose consumption at 6 hours for 
seven mutant E. coli strains and a control (MG1655 pCAA43 pDHC29) where (+) 
denotes transhydrogenase expression, (-) denotes transhydrogenase deletion, and (++) 
denotes transhydrogenase overexpression.   
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Chapter 4 
4.  Effects of Pyridine Nucleotide Transhydrogenases on the Production of  
Poly (3-hydroxybutyrate) in Escherichia coli 
 
4.1  Abstract 
 The effects of the energy-linked, membrane-bound (pntAB) and soluble, energy-
independent (udhA) transhydrogenase are examined in a poly(3-hyroxybutyrate) 
production system that utilizes acetoacetyl-CoA reductase to convert acetyl-CoA to PHB.  
The second step in the synthesis of PHB requires NADPH as a cofactor.  Mutant deletion 
strains lacking either one or both of the pyridine nucleotide transhydrogenases were 
shown to increase NADPH availability, resulting in increased concentration and yield of 
PHB in recombinant Escherichia coli.  Expression of the phb operon from Alcaligenes 
eutrophus H16 resulted in increased PHB concentration, most notably in the double 
deletion mutant strain (MG1655∆pntAB∆udhA pAet29) from 2.11 g/L to 5.07 g/L, a 
nearly 2.5 fold increase relative to the control.  PHB yield was increased from 61% to 
90% PHB per g of total dry cell weight as well.  These results provide insight on the roles 
of pyridine nucleotide transhydrogenases anddemonstrate the effectiveness of cofactor 
manipulation in metabolic engineering. 
 
4.2  Introduction 
 As mentioned in the previous chapter, cofactor pairs like NADH/NADPH are 
essential in the syntheses of industrially useful compounds (Gottschalk 1986).  These 
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cofactor pairs are utilized in redox reactions and act by transforming in a reversible 
manner between oxidized and reduced states.  As the production of high-value 
compounds like antibiotics, biodegradeable polymers, and chiral alcohols, to name a few, 
are dependent upon the availability of such low molecular weight cofactors, they act as a 
useful control parameter when studying cellular processes in the attempt to achieve 
specific metabolic engineering goals.  Unfortunately, their high cost hinders their use in 
large-scale industrial processes.  Studies implementing whole-cell biocatalysis, wherein 
effective cofactor regeneration can be achieved, are used.  These whole-cell systems 
present viable, cost-effective approaches for supplying and regenerating cofactor, but are 
limited by indigenous regeneration rates.   
This work focuses on the manipulating and characterizing NADPH availability in 
mutant Escherichia coli strains through the application of rational genetic modifications.  
Availability is assessed by determining product yields of cofactor-dependent products in 
E. coli.  This objective is achieved using classic metabolic engineering strategies such as 
the deletion of specific enzymes, using whole-cell fermentation systems to allow for 
more robust and cost-effective compound synthesis.  Specifically, NADPH availability is 
manipulated in an effort to increase product yield of the biodegradable polymer, poly (3-
hydroxybutyrate) (PHB).    
PHB is naturally produced by a variety of bacteria, accumulating as granules 
within the cytoplasm as an intracellular energy reserve (Anderson, 1990).  The 
biopolymer is a biodegradable, semi-crystalline thermoplastic that possesses 
biocompatible properties (Doi, 1990).  The PHB synthesis pathway and associated 
enzymes have been studied previously in Alcaligenes eutrophus by Haywood et al. (1988, 
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1989), and the phbC-phbA-phbB operon containing the three genes encoding the 
synthase-thiolase-reductase enzymes, respectively, have been cloned an analyzed as well 
(Steinbuchel, 1991).  Previous studies have shown that, when cloned and expressed in E. 
coli, a large amount of PHB accumulation is observed (Kusaka 1997, Sanchez 2006, 
Schubert 1988, Slater 1988).   
In this study, the effect of the two transhydrogenases, the membrane-bound, 
energy-linked isoform pntAB and the soluble, energy-independent isoform udhA, were 
assessed by constructing unique mutant deletion strains containing the PHB operon 
needed for PHB synthesis from acetyl-CoA in E. coli as indicated in the pathway 
depicted n Figure 4-1.  The first enzyme when synthesizing PHB from acetyl-CoA, β-
ketothiolase, is encoded by the gene phbA.  Two acetyl-CoA molecules are transformed 
in a reversible condensation reaction into acetoacetyl-CoA, and this intermediate is 
reduced to 3-hydroxybutryl-CoA by the NADPH-linked acetoacetyl-CoA reductase 
(phbB).  The polymerization of 3-hydroxybutryl-CoA is catalyzed by PHB synthase 
(phbC) to form the biodegradable polymer poly(3-hydroxybutryrate), or PHB.  (Kusaka 
2007, Sanchez 2006).   
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Figure 4-1.  Synthesis pathway for poly(3-hydroxybutyrate) in Escherichia coli under 
aerobic conditions.  (Sanchez 2006) 
  
PHB is chosen as a model system when investigating the effects of NADPH 
availability because the second enzyme in the process of converting acetyl-CoA to PHB, 
acetoacetyl-CoA reductase, requires NADPH as a cofactor (Fig. 4-1).  As a result, the 
activity of this enzyme coupled with the NADPH pool present themselves as important 
regulating factors for PHB synthesis (Anderson 1990, Srienc 1998, Sanchez 2006).  
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Additionally, the production of PHB yields such large quantities that it acts as an 
NADPH drain (Sanchez, 2006).   
A previous study by Sanchez et al. demonstrated the effectiveness of cofactor 
manipulation as a tool in metabolic engineering.  In the study, overexpression of the 
soluble transhydrogenase, udhA, alongside expression of the phb operon in Escherichia 
coli was reported to increase both the productivity and yield of PHB in vivo.   
The two transhydrogenease isoforms in this study transfer electrons between 
NAD and NADP as shown in the following equation: 
 + 

↔	

+ . 
Here, we wish to extend upon findings from Sanchez et al. in an effort to gain a better 
understanding regarding the physiological role of pyridine nucleotide transhydrogenases 
in E. coli and the direction of the reaction they catalyze in NADPH shuffling.  Wild-type 
(MG1655) and mutant deletion E. coli strains were transformed with the pAet29 plasmid 
encoding the phb operon, and the functionality of this system was demonstrated in PHB 
production experiments.  The following results suggest that PHB yield can be increased 
upon increased NADPH availability.   
 
4.3  Materials and methods 
 Chemicals used in the following procedures were purchased from Sigma-Aldrich 
(St. Louis, MO), unless denoted otherwise.   
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4.3.1  Bacterial strains and plasmids 
The strains and plasmids used in this study are described in Table 4-1, below.  
Wild type (MG1655), single udhA (MBS601) and pntAB (MBS602) transhydrogenase 
mutants, and a double transhydrogenase mutant (MBS603) were transformed with 
plasmids pAet29, containing the PHB operon containing the genes phbA, phbB, and 
phbC required for the synthesis of PHB from acetyl-CoA in E. coli, and either pPNTAB 
carrying the pntAB gene or pUDHAC carrying the udhA gene.  pDHC29 was used as a 
control.  Construction of these strains is described in detail in section 2.1.2 of the 
Materials and Methods chapter. 
Table 4-1.  List of E. coli strains and plasmids used in this study. 
 Genotype References 
Strain   
MG1655 Wild type E. coli (F
-
 λ
-
) ATCC 47076 
MBS601 MG1655 ∆udhA This study 
MBS602 MG1655 ∆pntAB This study 
MBS603 MG1655 ∆pntAB ∆udhA This study 
Plasmids   
pDHC29 Cloning vector, Cm
R
 (Phillips et al. 2000) 
pAeT29 Encodes β-ketothiolase, 
NADPH-dependent 
acetoacetyl-CoA reductase, 
and PHB synthase enzymes 
from Alcaligenes eutrophus, 
Amp
R
 
ATCC 75207 
pPNTAB Proton-translocating 
pyridine nucleotide 
transhydrogenase gene 
(pntAB) from E. coli, in 
pDHC29, Cm
R 
This study 
pUDHAC Soluble pyridine nucleotide 
transhydrogenase gene 
(udhA) from E. coli in 
pDHC29, Cm
R
 
This study 
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4.3.2 Culture medium 
 Luria-Bertani (LB) broth medium contained 10 g/L tryptone (Amresco, Solon, 
OH), 5 g/L yeast extract (BD Biosciences, Franklin Lakes, NJ) and 10 g/L NaCl.  The LB 
medium was autoclaved at 121°C for 20-35 minutes, depending upon the volume of 
liquid being autoclaved.  After autoclaving, glucose, antibiotics, and other various 
compounds were added aseptically as need be in accordance with each experiment.  A 
cocktail mixture of ampicillin, carbenicillin, and oxacillin was added at a concentration of 
200 mg/L.  The LB medium used was supplemented with 2% glucose as specified in 
experimental procedures.  (Sanchez 2006) 
 
4.3.3  Cultivation conditions  
 Overnight precultures were prepared by inoculating a single colony into 5 mL LB 
supplemented with appropriate antibiotics with no glucose content and incubated 
overnight at 37 °C and 250 rpm.  Cultures were inoculated with 1% v/v of the overnight 
preculture (e.g. 0.5 mL overnight preculture into a 250 mL flask containing 50 mL LB 
medium).  Aerobic shake flask experiments were performed using 250 mL shake flasks 
containing 50 mL of LB media.  The LB media was supplemented with a cocktail 
mixture of ampicillin, carbenicillin, and oxacillin to a final concentration of 200 mg/L 
and 2% glucose.  Flasks were capped with foam stoppers and grown in in an Excella E25 
rotary shaker (New Brunswick Scientific, Enfield, CT) at 37 °C and 250 rpm.  Samples 
of the culture were taken at 24 and 31 hours and analyzed for poly(3-hydroxybutyrate) 
and extracellular metabolite production. 
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4.3.4  Inoculum preparation and conditions for poly(3-hydroxybutyrate) production 
experiments 
For each experiment, wild-type, single udhA and pntAB transhydrogenase 
mutants, and the double transhydrogenase mutant were freshly transformed with the 
pAet29 plasmid.  A single colony was restreaked onto a plate containing 200 mg/L of a 
cocktail mixture of ampicillin, carbenicillin, and oxacillin.  A single colony was 
transferred into 5  mL LB supplemented with 200 mg/L of a cocktail mixture of 
ampicillin, carbenicillin, and oxacillin, and grown overnight aerobically at 37°C and 250 
rpm in an Excella E25 rotary shaker (New Brunswick Scientific, Enfield, CT).  Cells 
were inoculated at 1% v/v into 250 mL shake flasks containing 50 mL of LB media 
supplemented with 200 mg/L of a cocktail mixture of ampicillin, carbenicillin, and 
oxacillin and supplemented with 2% glucose.  Flasks were grown aerobically at 37°C and 
250 rpm.   
 
4.3.5  Analytical techniques 
4.3.5.1  Cell density 
 Cell density (OD) was taken at 600nm in a DU 800 spectrophotometer (Beckman 
Coulter, Irving, TX).  Culture samples were diluted, as appropriate, with LB medium to 
maintain readings in the linear range of the spectrophotometer (0.1-0.4 OD600).   
 
4.3.5.2  Analysis of extracellular metabolites 
 In order to quantify extracellular metabolites, 1 mL of the fermentation broth was 
sampled and centrifuged at 13,000 g for 3 minutes in a microcentrifuge.  The supernatant 
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was filtered through a 0.2 µm PTFE syringe filter and stored frozen for HPLC analysis.  
A Shimadzu-10A HPLC System (Shimadzu Scientific Instruments, Columbia, MD) 
equipped with a cation-exchange column (HPX-87H, BioRad Labs, Hercules, CA), a UV 
detector (Shimadzu SPD-10A), and a differential refractive index detector, RI, (Waters, 
Milford, MA) was used to detect extracellular metabolites such as glucose, succinate, 
lactate, and acetate, among others.  A solution of 2.5 mM H2SO4 was used as the mobile 
phase and operated at a0.5 mL/min flow rate.  The column was operated at 55°C.   
 
4.3.5.3  PHB extraction 
 Samples for PHB extraction were withdrawn aseptically after 24 and 31 hours of 
cultivation.  A 20 mL sample was withdrawn from the aerobic shake flasks at each 
timepoint, washed three times with 0.15 N NaCl and resuspended in 15 mL of 0.15 N 
NaCl.  Resuspended cells were transferred to preweighed and predried glass tubes and 
dried to constant weight using dry nitrogen.  A control tube containing 15 mL of 0.15 N 
NaCl was concurrently dried to constant weight and subtracted from the sample’s 
measured dry cell weight.  Samples of PHB-containing dry cell mass were digested in 2 
mL of concentrated H2SO4 for 45 minutes at 100°C on a heating block.  After cooling on 
ice, 10 mL of 0.014 N H2SO4 was added to the tubes and vortexed to ensure rapid 
mixing.  Extracted samples were diluted once more with 0.014 N H2SO4 to a final 
dilution factor ranging from 12-72, as needed.  (Sanchez, 2006) 
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4.3.5.4  Analysis of PHB production 
 PHB production was quantified using a Shimadzu-10A HPLC System (Shimadzu 
Scientific Instruments, Columbia, MD) equipped with a cation-exchange column (HPX-
87H, BioRad Labs, Hercules, CA), a UV detector (Shimadzu SPD-10A), and a 
differential refractive index detector, RI, (Waters, Milford, MA).  Approximately 1 mL of 
the diluted extract was centrifuged at 13,000 g for 3 minutes in a microcentrifuge.  The 
supernatant was filtered through a 0.2 µm PTFE syringe filter and stored chilled for 
HPLC analysis.  The mobile phase used was a 2.5 mM H2SO4 solution at a flow rate of 
0.6 mL/min.  The column was operated at 55°C.   
 The amount of PHB produced was calculated based upon a method developed by 
Karr et al. (Karr et al., 1983).  The absorbance of crotonic acid was measured at 210 nm 
with a retention time of 25.2 minutes.  The amount of crotonic acid derived from PHB 
was calculated using a known standard calibration curve of crotonic acid.  PHB content 
was estimated based upon the amount of crotonic acid detected using the previously 
determined conversion rate of PHB to crotonic acid of 1.81, as described by Taguchi et 
al. (Taguchi et al., 2001).   
 
4.4  Results and discussion 
 Aerobic shake flask experiments were performed with control and mutant deletion 
strains in LB medium supplemented with 2% glucose.  PHB biopolymers accumulated in 
the presence of glucose.  Three mutant deletion strains were evaluated against a control 
strain (MG1655), each containing the PHB operon containing β-ketothiolase, NADPH-
dependent acetoacetyl-CoA reductase, and PHB synthase enzymes from Alcaligenes 
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eutrophus (pAet29).  MG1655, MBS601, MBS602, and MBS603 were all freshly 
transformed with pAet29, and the experiments were performed under aerobic conditions 
in LB medium supplemented with a cocktail mixture of ampicillin, carbenicillin, and 
oxacillin at a concentration of 200 mg/L and 2% glucose.   
The results of these experiments at 31 hours are shown in Table 4-2.  The deletion 
of transhyrdogenases under aerobic conditions significantly increased the optical density 
of the culture while decreasing the acetate expression.  Glucose consumption was 
significantly higher in the mutant deletion strains compared to the control, increasing by 
81% in the udhA knockout strain and 62% in the double deletion strain.  As suggested in 
a previous study by Sanchez et al. (2006), the slight decrease in acetate yield could be 
due to increased carbon utilization in redox balancing pathways, wherein a higher 
production rate of NADPH is balanced out by redirecting flux from the NADPH-
producing TCA cycle to the non-NADPH-producing PEP-glyoxylate cycle in E. coli as 
described by Fischer et al. (2003).  The PEP-glyoxylate cycle is known to oxidize two 
PEP molecules by means of acetyl-CoA, citrate, glyoxylate, and oxaloacetate to CO2, 
regenerating one PEP molecule in the process.  Fischer and Sauer reported an active PEP-
glyoxylate cycle in glucose excess batch cultures of NADPH-overproducing 
phosphorglucose isomerase (pgi) mutant E. coli strains, suggesting its role in redox-
cofactor balancing in a manner similar to that of udhA.  UdhA has been reported to have a 
prominent role in NADPH abundant conditions, facilitating the reduction of NAD+ to 
NADH using NADPH as the electron donor (Canonaco 2001, Sauer 2004).  Likewise, the 
PEP-glyoxylate cycle has potential role under conditions where NADPH formation rates 
exceed its consumption (Fischer, 2003).   
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 The two mutant deletion strains, MBS601 pAet29 and MBS603 pAet29, 
consumed a considerably higher amount of glucose (P < 0.05, see Appendix).  The 
mutant deletion strain MBS602 pAet29 did not produce reportable results due to 
suspected plasmid loss.  Both strains produced significantly lower amounts of acetate (P 
< 0.05, see Appendix).   
 
Table 4-2  Optical densities, glucose consumption, and specific metabolite yields of 
cultures of MG1655 control and mutant deletion strains under aerobic conditions in LB 
medium supplemented with 2% glucose as a carbon source  at 31 hours.  Standard 
deviations of triplicate cultures are shown in parentheses.  ND = not detected due to 
plasmid loss. 
Strain OD600 nm 
Glucose Consumed  
(mM) 
Acetate Concentration 
 (mM) 
MG1655 pAet29 
udhA+ pntAB+ 
11.33 ± 0.18 49.41 ± 2.17 54.07 ± 0.25 
MBS601 pAet29 
udhA- pntAB+ 
18.64 ± 0.87 89.62 ± 6.61 48.18 ± 1.08 
MBS602 pAet29 
udhA+ pntAB- 
ND ND ND 
MBS603 pAet29 
udhA- pntAB- 
22.06  ± 0.64 79.81 ± 2.45 47.76 ± 0.69 
 
The reduced concentration of acetate in mutant deletion strains substantiates increased 
demand for acetyl-CoA.  Acetate production decreases by 11% in the udhA deletion 
strain and by 12% in the double deletion strain (∆pntAB ∆udhA).   
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 Results on PHB concentration at 31 hours during the shake flask study are shown 
in Figure 4-2.  PHB concentration was highest in the double deletion strain lacking both 
transhydrogenases (MBS603 pAet29), which produced 5.07 g/L of PHB during 31 hours 
of growth using glucose as the sole carbon source.  The control strain produced 2.11 g/L 
of PHB.  Therefore, the double deletion strain exhibited a 140% increase in PHB levels 
over the control.  The single deletion strain (MBS601 pAet29) lacking udhA produced 
4.46 g/L PHB after 31 hours of cultivation, which represents a 110% increase in PHB 
levels over the control.  These results conform to those reported by Lee et al. (1996).  Lee 
et al. concluded that one of the most critical regulating factors for PHB synthesis in 
recombinant E. coli was NADPH availability.  Additionally, they reported that low citrate 
synthase activity, which catalyzes the funneling of acetyl-CoA into the TCA cycle, 
contributes to higher PHB synthesis, suggesting that both NADPH and acetyl-CoA 
availability are pertinent for the efficient synthesis of PHB in E. coli.   
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Figure 4-2  PHB concentration of control and mutant deletion strains after 31 hours of 
cultivation in aerobic shake flask experiments in LB medium supplemented with 2% 
glucose.  MBS601 = MG1655∆udhA, MBS603 = MG1655∆pntAB∆udhA.  Error bars 
represent standard deviations of triplicate samples.   
 
 Figure 4-3 shows the PHB yield obtained during the shake flask study.  PHB yield 
is reported as the percentage of PHB per gram total dry cell weight.  Both mutant deletion 
strains increased PHB yield, though only slightly in the udhA deletion strain (from 61% 
to 65%).  The double deletion strain, on the other hand, had a significantly higher PHB 
yield than the control (P < 0.05, see Appendix), increasing it from 61% to 90%.  These 
results indicate that a larger proportion of the cells’ resources is being directed towards 
PHB production rather than residual cell mass production, wherein residual cell mass is 
defined as total dry cell weight minus grams of PHB produced (Sanchez, 2006).   
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Figure 4-3  PHB yield of control and mutant deletion strains after 31 hours of cultivation 
in aerobic shake flask experiments in LB medium supplemented with 2% glucose.  
MBS601 = MG1655∆udhA, MBS603 = MG1655∆pntAB∆udhA.  Error bars represent 
standard deviations of triplicate samples.   
 
 This study aimed to determine transhydrogenase effects on NADPH availability, 
which was measured through the synthesis of PHB.  The results suggest that increased 
NADPH availability, achieved through single and double mutant deletion strains, 
promote PHB synthesis.  High levels and yields of PHB were obtained within 31 hours of 
culturing under aerobic conditions.  Cofactor manipulation using transhydrogenases was 
shown to be an effective tool when attempting to increase productivity of cofactor-
dependent compounds.  Future work can be done to investigate the effects of 
transhydrogenase overexpression in control and mutant backgrounds in addition to the 
effects of a pntAB deletion strain.   
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Appendix 
Appendix A – Statistical analysis of aerobic (S)-2-chloropropionate production results 
Aerobic (S)-2-chloroproprionate production experiments: 
Product Yield/Glucose consumption 
Groups Count Sum Average Variance 
MG1655 pCAA43 pDHC29 3 1.71 0.570665 0.00026 
MBS603 pCAA43 pDHC29 3 2.42 0.807538 0.00166 
MBS602 pCAA43 pDHC29 3 3.76 1.25223 0.00448 
MBS601 pCAA43 pDHC29 3 2.18 0.727108 6.2E-05 
MG1655 pCAA43 pntAB+ 3 1.56 0.519068 0.00012 
MG1655 pCAA43 udhA+ 3 2.6 0.865572 0.00013 
MBS603 pCAA43 pntAB+ 3 0.65 0.215074 5.2E-06 
MBS603 pCAA43 udhA+ 3 2.78 0.925205 3.3E-05 
ANOVA Results 
Source of Variation SS df MS F 
P-
value F crit 
Between Groups 2.0101 7 0.28716 339.71 
3.5E-
16 2.6572 
Within Groups 0.01352 16 0.00085 
Total 2.02362 23         
 
Aerobic (S)-2-chloroproprionate production experiments: Product Yield/Glucose 
consumption in udhA-expressing strains 
Groups Count Sum Average Variance 
MG1655 pCAA43 pntAB 3 1.5572 0.51907 0.000125 
MG1655 pCAA43 pDHC29 3 1.712 0.57067 0.000265 
MBS602 pCAA43 pDHC29 3 3.7567 1.25223 0.00448 
ANOVA Results 
Source of Variation SS df MS F P-value F crit 
Between Groups 1.00472 2 0.502 309.5452 
8.844E-
07 5.143253 
Within Groups 0.00974 6 0.002 
Total 1.01446 8         
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Aerobic (S)-2-chloroproprionate production experiments: Product Yield/Glucose 
consumption in udhA-deletion strains 
Groups Count Sum Average Variance 
MBS601 pCAA43 pDHC29 3 2.18 0.727 6.18E-05 
MBS603 pCAA43 pDHC29 3 2.42 0.808 0.001663 
ANOVA Results 
Source of 
Variation SS df MS F P-value F crit 
Between Groups 0.0097 1 0.01 11.25 0.02847 7.708647 
Within Groups 0.00345 4 
9E-
04 
Total 0.01315 5         
 
 
Aerobic (S)-2-chloroproprionate production experiments: Product Yield/Glucose 
consumption in pntAB deletion strains  
Groups Count Sum Average Variance 
MBS603 pCAA43 pDHC29 3 2.42 0.808 0.002 
MBS602 pCAA43 pDHC29 3 3.76 1.252 0.004 
MBS602 pCAA43 udhA 3 4.33 1.442 0.005 
Source of 
Variation SS df MS F P-value F crit 
Between 
Groups 0.63682 2 0.318 88.25 3.6E-05 5.143 
Within Groups 0.02165 6 0.004 
Total 0.65847 8         
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Appendix B – Statistical analysis of anaerobic (S)-2-chloropropionate production results 
 
Anaerobic (S)-2-chloroproprionate production experiments: Product Yield/Glucose 
consumption 
Groups Count Sum Average Variance 
MG1655 pCAA43 pDHC29 3 1.656741 0.552247 0.00027 
MBS603 pCAA43 pDHC29 3 2.288473 0.762824 0.000677 
MBS602 pCAA43 pDHC29 3 3.161219 1.05374 0.002693 
MBS601 pCAA43 pDHC29 3 1.320505 0.440168 3.39E-07 
MG1655 pCAA43 pntAB+ 3 1.08773 0.362577 1.51E-07 
MG1655 pCAA43 udhA+ 3 1.877327 0.625776 8.84E-07 
MBS603 pCAA43 pntAB+ 3 0.449678 0.149893 3.78E-05 
MBS603 pCAA43 udhA+ 3 2.171618 0.723873 0.001 
Source of Variation SS df MS F 
P-
value F crit 
Between Groups 1.599349 7 0.2285 390.666 
1.15E-
16 2.657197 
Within Groups 0.009357 16 0.0006 
Total 1.608707 23         
 
 
Anaerobic (S)-2-chloroproprionate production experiments: Product Yield/Glucose 
consumption in udhA-expressing strains 
Groups Count Sum Average Variance 
MG1655 pCAA43 pntAB 3 1.0877 0.362577 2E-07 
MG1655 pCAA43 pDHC29 3 1.6567 0.552247 0.0003 
MBS602 pCAA43 pDHC29 3 3.1612 1.05374 0.0027 
Source of 
Variation SS df MS F P-value F crit 
Between Groups 0.76518 2 0.3826 387.35 4.54E-07 5.14325 
Within Groups 0.00593 6 0.001 
Total 0.7711 8         
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Anaerobic (S)-2-chloroproprionate production experiments: Product Yield/Glucose 
consumption in udhA-deletion strains 
Groups Count Sum Average Variance 
MBS601 pCAA43 pDHC29 3 1.3205 0.4402 3E-07 
MBS603 pCAA43 pDHC29 3 2.2885 0.7628 0.0007 
ANOVA Results 
Source of 
Variation SS df MS F P-value F crit 
Between Groups 0.15616 1 0.1562 461.35 2.78E-05 7.70865 
Within Groups 0.00135 4 0.0003 
Total 0.15751 5         
 
 
Anaerobic (S)-2-chloroproprionate production experiments: Product Yield/Glucose 
consumption in pntAB-deletion strains 
Groups Count Sum Average Variance 
MBS603 pCAA43 pDHC29 3 2.2885 0.7628 0.0007 
MBS602 pCAA43 pDHC29 3 3.1612 1.0537 0.0027 
MBS602 pCAA43 udhA 3 3.0489 1.0163 0.0019 
ANOVA Results 
Source of 
Variation SS df MS F 
P-
value F crit 
Between Groups 0.15029 2 0.0751 42.436 0.0003 5.14325 
Within Groups 0.01062 6 0.0018 
Total 0.16091 8         
 
 
Anaerobic (S)-2-chloroproprionate production experiments: Product Yield/Glucose 
consumption in pntAB-deletion strains, udhA-expressing strains 
Groups Count Sum Average Variance 
MBS602 pCAA43 pDHC29 3 3.16 1.05374 0.0027 
MBS602 pCAA43 udhA 3 3.05 1.01631 0.0019 
ANOVA Results 
Source of Variation SS df MS F P-value F crit 
Between Groups 0.0021 1 0.0021 0.9066 0.39494 7.70865 
Within Groups 0.00927 4 0.00232 
Total 0.01137 5         
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Appendix C – Statistical analysis of aerobic poly(3-hydroxybutyrate) production results 
 
 
Glucose consumption (mM)  ttest at 31 hours: 
Strain A Strain B P-Value 
MG1655 pAet29 MBS601 pAet29 5.58 E-4 
MG1655 pAet29 MBS603 pAet29 9.01 E-05 
 
Acetate concentration (mM) ttest at 31 hours: 
Strain A Strain B P-Value 
MG1655 pAet29 MBS601 pAet29 7.63 E-4 
MG1655 pAet29 MBS603 pAet29 1.18 E-05 
 
PHB yield per g total (%) ttest at 31 hours: 
Strain A Strain B P-Value 
MG1655 pAet29 MBS601 pAet29 0.297 
MG1655 pAet29 MBS603 pAet29 3.96 E-4 
 
PHB concentration (g/L) ttest at 31 hours: 
Strain A Strain B P-Value 
MG1655 pAet29 MBS601 pAet29 3.61 E-5 
MG1655 pAet29 MBS603 pAet29 7.34 E-6 
 
